پرش به محتوا
ابزار کمک‌تصمیم برای کادر درمان — جایگزین قضاوت بالینی نیست
دگزامد
→بازگشت به لیست همه دپارتمان‌های کشیک
20 پروتکل بالینی استاندارد · ۱۰۰٪ ژنریک INN

پکیج کشیک

کتاب مرجع اصلی:

تشدید حاد بیماری انسدادی مزمن ریه (AECOPD - معیارهای گلد)

(Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD - GOLD Guidelines))
ICD-10: J44.1مرجع: Murray & Nadel's Textbook of Respiratory Medicine - Ch. 44

📋 نکات شرح حال (History Pearls):

  • •Anthonisen cardinal criteria: Acute sustained worsening from baseline of dyspnea, sputum volume, and sputum purulence (Type 1: all 3 symptoms; Type 2: 2 of 3; Type 3: 1 of 3 plus upper respiratory infection, fever, or wheeze); purulent sputum strongly correlates with high bacterial burden
  • •Precipitating etiologies: Viral respiratory tract infections (rhinovirus, influenza, RSV in 30-50%), bacterial tracheobronchial infections (Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, Pseudomonas aeruginosa in severe airflow obstruction), and environmental pollutant or cold air exposure
  • •Patient risk stratification: Prior exacerbation history (>= 2 exacerbations or >= 1 hospitalization in past year indicates frequent exacerbator phenotype), baseline FEV1 < 50% predicted, home oxygen dependency, chronic hypercapnia, systemic corticosteroid dependency, and cardiovascular comorbidities (cor pulmonale, heart failure)

🩺 معاینه فیزیکی (Physical Exam):

  • •Respiratory distress assessment: Tachypnea (respiratory rate > 25-30 breaths/min), pursed-lip breathing, tripod positioning, intercostal retraction, and supraclavicular/sternocleidomastoid accessory muscle recruitment
  • •Thoracoabdominal dynamics: Paradoxical abdominal motion (Hoover sign - inward movement of lower rib cage during inspiration indicating severe diaphragmatic flattening), barrel chest deformity, hyperresonant percussion, distant breath sounds, and diffuse expiratory polyphonic wheezing with coarse rhonchi
  • •Hypercapnic encephalopathy & right heart failure signs: Asterixis (flapping tremor), lethargy, bounding peripheral pulses, warm vasodilated extremities, engorged jugular veins with prominent v-wave, loud pulmonic component of S2, tricuspid regurgitant murmur, tender hepatomegaly, and bilateral pitting lower extremity edema

🧪 آزمایشگاه و تصویربرداری:

  • •Arterial Blood Gas (ABG): Acute or acute-on-chronic respiratory acidosis (pH < 7.35, PaCO2 > 45-50 mmHg), hypoxemia (PaO2 < 60 mmHg or SpO2 < 88% on room air); calculation of alveolar-arterial (A-a) oxygen gradient helps differentiate simple hypoventilation from ventilation-perfusion mismatch
  • •Chest Radiography (PA & Lateral): Excludes competing mimickers or complications: spontaneous pneumothorax, lobar pneumonia/consolidation, congestive heart failure (pulmonary edema, Kerley B lines), or pleural effusion; shows hyperinflation with flattened diaphragmatic domes, increased retrosternal airspace (> 2.5 cm), and attenuated peripheral vasculature
  • •Laboratory & Microbial Evaluation: Complete blood count (eosinophil count >= 300 cells/uL or >= 2% predicts steroid responsiveness; leukocytosis with left shift indicates bacterial infection; polycythemia indicates chronic hypoxemia), serum electrolytes (BUN/creatinine, potassium, chloride), baseline ECG (reveals P-pulmonale, right axis deviation, RV strain, multifocal atrial tachycardia [MAT]), and sputum Gram stain with bacterial culture if frequent exacerbator or Pseudomonas risk

💊 دستورات بستری و درمانی (Generic INN):

  • ✓Diet/Activity: Semi-Fowler or high-Fowler upright positioning (30-45 degrees) to optimize diaphragmatic excursion; NPO during acute severe dyspnea, transitioning to small frequent low-carbohydrate meals once stabilized to reduce ventilatory CO2 production
  • ✓Monitoring: Continuous pulse oximetry titrated strictly to target SpO2 88-92% (to prevent worsening hypercapnia from Haldane effect and loss of hypoxic drive); continuous cardiac telemetry for arrhythmias (MAT, atrial fibrillation); repeat ABG within 30-60 minutes after initiating noninvasive ventilation or altering supplemental oxygen; daily weights and strict fluid balance
  • ✓IV Hydration: 0.9% Normal Saline or 5% Dextrose in 0.45% Saline at 50-75 mL/hr maintenance; avoid overhydration which precipitates cor pulmonale decompensation or pulmonary interstitial congestion, while avoiding dehydration which leads to thick, tenacious mucus impaction
  • ✓Pharmacotherapy (Generic Only): INHALED BRONCHODILATORS: Albuterol 2.5-5 mg nebulized every 20-30 minutes for 3 doses, then 2.5 mg every 2-4 hours PRN PLUS Ipratropium Bromide 0.5 mg nebulized every 4-6 hours; SYSTEMIC CORTICOSTEROIDS: Prednisone 40 mg orally once daily (or Methylprednisolone 40-60 mg IV every 12-24 hours if unable to take oral) for exactly 5 days (GOLD standard); ANTIMICROBIAL THERAPY (for Anthonisen Type 1 or Type 2 with purulent sputum, or requiring mechanical ventilation): Azithromycin 500 mg orally on day 1, then 250 mg orally daily for 4 days OR Amoxicillin-Clavulanate 875/125 mg orally every 12 hours for 5-7 days; if risk factors for Pseudomonas aeruginosa (FEV1 < 30%, bronchiectasis, recent hospitalization, frequent antibiotics): Ciprofloxacin 500 mg orally every 12 hours (or 400 mg IV every 12 hours) OR Levofloxacin 750 mg orally/IV daily for 7 days; VENOUS THROMBOEMBOLISM PROPHYLAXIS: Enoxaparin 40 mg subcutaneous once daily (or Unfractionated Heparin 5000 units subcutaneous every 8 hours); NONINVASIVE POSITIVE PRESSURE VENTILATION (NIV/BiPAP): First-line ventilatory support for acute hypercapnic respiratory acidosis (pH <= 7.35 and PaCO2 >= 45 mmHg) with initial IPAP 10-12 cmH2O, EPAP 4-5 cmH2O, titrated to alleviate work of breathing

⚠️ علائم خطر حیات (Red Flags):

  • !Acute worsening of respiratory acidosis (pH < 7.25 and PaCO2 > 60-65 mmHg) refractory to 1-2 hours of optimal noninvasive ventilation (BiPAP), signifying impending respiratory arrest requiring urgent endotracheal intubation
  • !Severe hemodynamic instability, sustained malignant ventricular arrhythmias, or acute mental status depression (stupor, coma, loss of airway protective reflexes) constituting absolute contraindications to continued noninvasive ventilation
  • !Development of sudden unilateral pleuritic chest pain with absent unilateral breath sounds and tracheal deviation (rupture of an apical bulla producing tension pneumothorax)

حمله حاد شدید آسم و وضعیت آسمی (استاتوس آسماتیکوس)

(Severe Acute Asthma & Status Asthmaticus)
ICD-10: J45.901مرجع: Murray & Nadel's Textbook of Respiratory Medicine - Ch. 42

📋 نکات شرح حال (History Pearls):

  • •Severe dyspnea progression: Acute onset or progressive refractory breathlessness, inability to complete full sentences in a single breath (words per breath < 3), profound chest tightness, and rapid exhaustion despite frequent self-administration of short-acting beta-agonists
  • •High-risk fatal asthma markers: Prior history of near-fatal asthma requiring endotracheal intubation or ICU admission, recent hospitalization or emergency department visits for asthma within past year, recent or current oral corticosteroid use, lack of inhaled corticosteroid adherence, and history of psychiatric illness or psychosocial stress
  • •Trigger identification: Acute respiratory viral infections (rhinovirus), heavy aeroallergen exposure, nonsteroidal anti-inflammatory drug (NSAID) or beta-blocker ingestion, occupational toxins, or rapid withdrawal of maintenance anti-inflammatory controller therapy

🩺 معاینه فیزیکی (Physical Exam):

  • •Visual inspection & speech pattern: Patient sitting bolt upright in tripod position, diaphoresis, speaking in monosyllables or short fragments, pronounced suprasternal and intercostal accessory muscle retractions
  • •Auscultation & 'Silent Chest': Loud diffuse biphasic expiratory and inspiratory polyphonic wheezing; critical observation: sudden disappearance of wheezing with 'silent chest' signifies critically reduced airflow, air trapping, and impending respiratory arrest, rather than clinical improvement
  • •Pulsus paradoxus & hemodynamic signs: Marked tachycardia (HR > 120 bpm), tachypnea (RR > 30 breaths/min), and pulsus paradoxus (exaggerated inspiratory fall in systolic blood pressure > 12-15 mmHg measured via manual sphygmomanometer) reflecting severe intrathoracic pressure swings and dynamic hyperinflation

🧪 آزمایشگاه و تصویربرداری:

  • •Bedside Spirometry / Peak Expiratory Flow (PEF): Peak flow < 50% of personal best or predicted (< 200 L/min in adults) signifies severe acute asthma; PEF < 25-33% indicates life-threatening asthma
  • •Arterial Blood Gas (ABG): Early phase reveals respiratory alkalosis with hypoxemia (low PaCO2 < 35 mmHg, low PaO2); a 'normal' PaCO2 (38-42 mmHg) or elevated PaCO2 (> 45 mmHg) with respiratory acidosis (pH < 7.35) indicates respiratory muscle fatigue, severe airflow obstruction, and impending respiratory failure
  • •Imaging & Laboratory Diagnostics: Portable upright chest radiograph (evaluates for pneumothorax, pneumomediastinum, atelectasis from mucus plugging, or aspiration pneumonia); complete blood count (peripheral eosinophilia, leukocytosis often secondary to stress or steroids); serum potassium (frequent nebulized beta-agonists induce transcellular shift causing marked hypokalemia)

💊 دستورات بستری و درمانی (Generic INN):

  • ✓Diet/Activity: Strict NPO during severe acute attack; bed rest in upright sitting position (high-Fowler); maintain calm, reassuring environment to reduce anxiety-induced hyperventilation
  • ✓Monitoring: Continuous pulse oximetry (target SpO2 93-95% in non-pregnant adults, >= 95% in pregnancy); continuous cardiac telemetry (monitor for sinus tachycardia, ventricular ectopy, and QTc prolongation); serial PEF measurements at 30, 60, and 120 minutes post-treatment; serial serum potassium and glucose every 2-4 hours
  • ✓IV Hydration: Intravenous crystalloid infusion with 5% Dextrose in 0.45% Saline or 0.9% Normal Saline at 100-150 mL/hr to replace insensible fluid losses from hyperventilation and diaphoresis, avoiding hypovolemia-induced hemoconcentration and viscous mucus plugging
  • ✓Pharmacotherapy (Generic Only): INHALED RAPID-ACTING BRONCHODILATORS: Albuterol 5 mg nebulized continuously over 1 hour (or 2.5-5 mg every 20 minutes for 3 doses) PLUS Ipratropium Bromide 0.5 mg nebulized every 20 minutes for 3 doses, then every 4-6 hours; SYSTEMIC CORTICOSTEROIDS: Methylprednisolone 60-80 mg IV every 6-8 hours (or Hydrocortisone 100-200 mg IV every 6 hours; oral Prednisone 50 mg if tolerated); INTRAVENOUS MAGNESIUM SULFATE: Magnesium Sulfate 2 g IV infused in 100 mL 0.9% Normal Saline over 20 minutes (potent bronchodilator through smooth muscle calcium channel inhibition); INTRAMUSCULAR/SUBCUTANEOUS EPINEPHRINE (for severe refractory spasm, impending collapse, or anaphylaxis): Epinephrine 0.3-0.5 mg (0.3-0.5 mL of 1:1000 / 1 mg/mL solution) intramuscularly every 20 minutes for up to 3 doses; SUPPLEMENTAL OXYGEN: Oxygen delivered via nasal cannula or simple mask titrated to target SpO2 93-95%; MECHANICAL VENTILATION STRATEGY (if intubated for arrest): Rapid sequence intubation with Ketamine 1.5-2 mg/kg IV and Rocuronium 1.2 mg/kg IV; mechanical ventilator settings adopting permissive hypercapnia, low tidal volume (6-8 mL/kg ideal body weight), low respiratory rate (10-12 breaths/min), prolonged expiratory time (I:E ratio 1:3 to 1:4), and low PEEP (0-5 cmH2O) to prevent dynamic hyperinflation (auto-PEEP) and barotrauma

⚠️ علائم خطر حیات (Red Flags):

  • !Development of 'silent chest' with loss of audible breath sounds, accompanied by bradycardia, confusion, somnolence, or exhaustion (signals imminent cardiorespiratory arrest)
  • !Pseudonormalization or elevation of PaCO2 (> 42-45 mmHg) in a tachypneic patient, demonstrating respiratory pump failure and diaphragmatic exhaustion
  • !Tension pneumothorax or pneumomediastinum presenting with acute asymmetric chest expansion, subcutaneous crepitus, severe hypotension, and tracheal deviation

سندرم زجر تنفسی حاد بزرگسالان (ARDS - معیارهای برلین)

(Acute Respiratory Distress Syndrome (ARDS - Berlin Definition))
ICD-10: J80مرجع: Murray & Nadel's Textbook of Respiratory Medicine - Ch. 104

📋 نکات شرح حال (History Pearls):

  • •Timing & inciting clinical insult: Onset of acute hypoxemic respiratory failure within 1 week of a known direct pulmonary insult (pneumonia, aspiration of gastric contents, pulmonary contusion, inhalation injury, near-drowning) or indirect systemic insult (sepsis, severe pancreatitis, multiple trauma, massive transfusion [TRALI], severe burns)
  • •Symptom progression: Rapidly escalating dyspnea, extreme tachypnea, intractable air hunger, progressive cyanosis, and severe hypoxemia refractory to high concentrations of supplemental oxygen
  • •Pre-existing cardiopulmonary evaluation: Absence of primary left atrial hypertension or isolated hydrostatic pulmonary edema; history of chronic renal failure or volume overload evaluated to exclude pure cardiogenic edema

🩺 معاینه فیزیکی (Physical Exam):

  • •Respiratory mechanics & auscultation: Profound tachypnea (RR > 35-40 breaths/min), intercostal retractions, grunting, diffuse inspiratory coarse crackles and bronchial breath sounds auscultated bilaterally across both lung fields
  • •Hypoxemia & tissue perfusion: Central cyanosis, cool mottled extremities, delayed capillary refill, diaphoresis, and agitated delirium transitioning to obtundation secondary to severe tissue hypoxia
  • •Hemodynamic & volume assessment: Elevated central venous pressure or normal JVP; bedside assessment to differentiate from left heart failure (absence of S3 gallop, absence of murmurs of acute severe mitral regurgitation or aortic dissection)

🧪 آزمایشگاه و تصویربرداری:

  • •Berlin Definition Severity Stratification (ABG on PEEP >= 5 cmH2O): Mild ARDS (PaO2/FiO2 201-300 mmHg); Moderate ARDS (PaO2/FiO2 101-200 mmHg); Severe ARDS (PaO2/FiO2 <= 100 mmHg)
  • •Chest Radiography & High-Resolution CT: Bilateral opacities not fully explained by effusions, lobar/lung collapse, or nodules; diffuse alveolar ground-glass infiltrates, consolidation with air bronchograms, and dependent lung density ('baby lung' concept)
  • •Echocardiography & Biomarkers: Transthoracic echocardiography demonstrates normal left ventricular systolic function with normal left ventricular filling pressures (E/e' < 14) and no acute valvulopathy, effectively excluding cardiogenic hydrostatic edema; elevated plasma brain natriuretic peptide (BNP) or NT-proBNP interpreted cautiously as sepsis-induced RV strain can elevate BNP

💊 دستورات بستری و درمانی (Generic INN):

  • ✓Diet/Activity: Strict NPO during invasive mechanical ventilation; early enteral nutrition initiated via post-pyloric or nasogastric tube within 24-48 hours once hemodynamically stabilized; strict bed rest with early protocolized passive physical therapy
  • ✓Monitoring: Continuous arterial line blood pressure monitoring, serial ABG analysis every 2-4 hours, continuous pulse oximetry (target SpO2 88-92%), plateau pressure monitoring (target Pplat <= 30 cmH2O), driving pressure monitoring (Delta P = Pplat - PEEP, target <= 14 cmH2O), continuous end-tidal CO2 (ETCO2), and central venous pressure/ScvO2 monitoring
  • ✓IV Hydration: Conservative fluid management strategy (FACTT trial protocol): restrictive crystalloid therapy with target neutral to negative net fluid balance once septic shock resuscitation is achieved (central venous pressure < 4 mmHg or stroke volume variation optimized), utilizing Furosemide continuous infusion or boluses (e.g., Furosemide 20-40 mg IV every 8-12 hours) if hemodynamically stable
  • ✓Pharmacotherapy (Generic Only): LUNG-PROTECTIVE MECHANICAL VENTILATION (ARDSNet Protocol): Volume-assist control ventilation with low tidal volume (initial 6 mL/kg ideal body weight, titrating down to 4 mL/kg if Pplat > 30 cmH2O), titration of PEEP and FiO2 via high-PEEP/lower-FiO2 ARDSNet grid (PEEP 10-24 cmH2O), permissive hypercapnia (target arterial pH >= 7.20-7.25); PRONE POSITIONING: Early prolonged prone positioning (>= 16 consecutive hours daily) for moderate-to-severe ARDS (PaO2/FiO2 < 150 mmHg); NEUROMUSCULAR BLOCKADE: Cisatracurium 150 mcg/kg IV bolus followed by 1-3 mcg/kg/min continuous infusion (or intermittent boluses) for 48 hours in severe ARDS with severe patient-ventilator dyssynchrony; ANALGO-SEDATION: Fentanyl 50-100 mcg/hr IV continuous infusion PLUS Midazolam 2-5 mg/hr IV (or Propofol 5-50 mcg/kg/min IV, monitoring for propofol infusion syndrome); SYSTEMIC CORTICOSTEROIDS (in non-viral early ARDS, Meduri protocol): Methylprednisolone 1 mg/kg/day IV continuous infusion or divided every 6 hours for 14 days, with gradual taper; INHALED VASODILATORS (rescue for refractory hypoxemia): Inhaled Epoprostenol 10-50 ng/kg/min or Inhaled Nitric Oxide 10-20 ppm; EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO): Consider venovenous (VV) ECMO for refractory hypoxemia (PaO2/FiO2 < 80 mmHg for > 6 hours or PaO2/FiO2 < 50 mmHg for > 3 hours) despite lung-protective ventilation and neuromuscular blockade

⚠️ علائم خطر حیات (Red Flags):

  • !Refractory hypoxemia with PaO2/FiO2 ratio < 80 mmHg despite FiO2 1.0, high PEEP, neuromuscular blockade, and prone positioning (indicating catastrophic shunt requiring rescue ECMO)
  • !Sudden drop in compliance, acute rise in peak and plateau airway pressures (> 35 cmH2O), and profound hemodynamic collapse (indicating tension pneumothorax or barotrauma secondary to high PEEP)
  • !Acute cor pulmonale on echocardiography with severe right ventricular dilatation, septal dyskinesia, and acute hemodynamic collapse secondary to elevated pulmonary vascular resistance

آمبولی ریه ماسیو و پرخطر با نارسایی حاد بطن راست

(Massive High-Risk Pulmonary Thromboembolism (PE with Obstructive Shock))
ICD-10: I26.02مرجع: Murray & Nadel's Textbook of Respiratory Medicine - Ch. 85

📋 نکات شرح حال (History Pearls):

  • •Abrupt onset symptoms: Sudden agonizing dyspnea, pleuritic or crushing substernal chest pain, syncope or presyncope (heralds occlusion of > 50% of the pulmonary arterial bed), hemoptysis, and acute impending sense of death
  • •Virchow's triad risk factors: Prolonged immobilization, recent major orthopedic or pelvic surgery, active occult or diagnosed malignancy, prior deep vein thrombosis (DVT) or PE, estrogen therapy, pregnancy/postpartum, antiphospholipid syndrome, and inherited thrombophilias (Factor V Leiden, Prothrombin G20210A)
  • •Pre-collapse warning signs: Unilateral leg pain, calf swelling, warmth, or erythema preceding sudden cardiorespiratory collapse

🩺 معاینه فیزیکی (Physical Exam):

  • •Obstructive shock signs: Sustained hypotension (systolic BP < 90 mmHg or systolic BP drop >= 40 mmHg for > 15 minutes not caused by new-onset arrhythmia, hypovolemia, or sepsis), profound cold clammy extremities, cyanosis, and delayed capillary refill
  • •Acute cor pulmonale examination: Markedly elevated jugular venous pressure with prominent 'a' and 'v' waves, left parasternal heave, widely split second heart sound (S2) with an accentuated pulmonic component (P2), tricuspid regurgitant systolic murmur that increases with inspiration (Carvallo sign), and right-sided S3 gallop
  • •Respiratory examination: Severe tachypnea (RR > 30 breaths/min), tachycardia (HR > 110-120 bpm), clear lung auscultation (characteristic mismatch between profound dyspnea and clear lung fields, or localized crackles/pleural friction rub over pulmonary infarction)

🧪 آزمایشگاه و تصویربرداری:

  • •CT Pulmonary Angiography (CTPA): Definitive imaging modality demonstrating large filling defects, saddle embolus straddling the main pulmonary artery bifurcation, or extensive occlusive lobar/segmental thrombi, with right ventricular strain (RV/LV diameter ratio > 1.0 on transverse reconstructed views, straightening/flattening of the interventricular septum)
  • •Bedside Echocardiography (TTE/TEE): Rapid bedside tool for unstable patients demonstrating RV dilatation and hypokinesia with sparing of the RV apex (McConnell sign), systolic flattening of the interventricular septum ('D-shaped' left ventricle), elevated tricuspid regurgitant jet velocity (> 2.8 m/s), and visualization of mobile thrombus in the right heart chambers or main pulmonary trunk
  • •Laboratory & ECG Markers: Marked elevation of high-sensitivity cardiac Troponin I/T (myocardial microinfarction from RV ischemia) and NT-proBNP / BNP (RV wall stress); 12-lead ECG demonstrates sinus tachycardia, classic S1Q3T3 pattern (prominent S in lead I, Q wave in lead III, inverted T wave in lead III), new complete or incomplete right bundle branch block (RBBB), and precordial T-wave inversions in leads V1-V4

💊 دستورات بستری و درمانی (Generic INN):

  • ✓Diet/Activity: Strict NPO, strict bed rest with continuous invasive hemodynamic monitoring; avoid unnecessary patient repositioning or Valsalva maneuvers which can trigger further clot embolization
  • ✓Monitoring: Continuous arterial line blood pressure monitoring, central venous pressure monitoring, continuous 12-lead ECG telemetry, continuous pulse oximetry, hourly urine output via Foley catheter (target > 0.5 mL/kg/hr), and serial lactate levels
  • ✓IV Hydration: Cautious conservative fluid administration: 0.9% Normal Saline limited to a single 250-500 mL bolus over 15-30 minutes; excessive fluid loading overdistends the failing right ventricle, shifts the interventricular septum leftward, and worsens left ventricular underfilling and systemic cardiogenic shock
  • ✓Pharmacotherapy (Generic Only): SYSTEMIC THROMBOLYTIC THERAPY (First-line for Massive PE): Alteplase (Recombinant Tissue Plasminogen Activator) 100 mg IV infusion administered over 2 hours; OR accelerated regimen in cardiac arrest/imminent collapse: Alteplase 50 mg IV bolus over 2 minutes (may repeat 50 mg in 15 minutes if no ROSC); OR Tenecteplase weight-adjusted IV bolus over 5-10 seconds (< 60 kg: 30 mg; 60-69 kg: 35 mg; 70-79 kg: 40 mg; 80-89 kg: 45 mg; >= 90 kg: 50 mg); PARENTERAL ANTICOAGULATION: Unfractionated Heparin 80 units/kg IV bolus followed by 18 units/kg/hr continuous infusion, titrated to maintain target aPTT 1.5-2.5 times control (60-80 seconds) or anti-Xa 0.3-0.7 IU/mL (withhold heparin infusion during 2-hour Alteplase infusion, resume immediately without bolus once aPTT < 2 times control); VASOPRESSOR AND INOTROPIC SUPPORT: Norepinephrine 0.05-0.5 mcg/kg/min IV titrated to maintain MAP >= 65 mmHg; add Epinephrine 0.05-0.3 mcg/kg/min or Dobutamine 2.5-10 mcg/kg/min if persistent RV pump failure; CATHETER-DIRECTED OR SURGICAL INTERVENTION: If systemic thrombolysis is contraindicated (active internal bleeding, recent intracranial hemorrhage/stroke, major trauma/surgery < 3 weeks) or fails: Immediate Catheter-Directed Pharmacomechanical Thrombolysis (CDT) or Surgical Pulmonary Embolectomy

⚠️ علائم خطر حیات (Red Flags):

  • !Pulseless Electrical Activity (PEA) arrest or refractory shock secondary to complete right ventricular outflow tract obstruction
  • !Severe intracranial hemorrhage or massive internal gastrointestinal/retroperitoneal bleeding following systemic thrombolytic administration
  • !Acute worsening of paradoxical embolism via a patent foramen ovale (PFO), leading to acute ischemic stroke or peripheral limb ischemia

پنومونی حاد شدید اکتسابی از جامعه (CAP - معیارهای ATS/IDSA)

(Severe Community-Acquired Pneumonia (Severe CAP - ATS/IDSA Criteria))
ICD-10: J18.9مرجع: Murray & Nadel's Textbook of Respiratory Medicine - Ch. 34

📋 نکات شرح حال (History Pearls):

  • •Acute infectious respiratory presentation: High spiking fevers, shaking chills (rigors), productive cough with purulent or rust-colored sputum, pleuritic chest pain, and severe progressive shortness of breath
  • •Severity risk scoring: Assessment of ATS/IDSA Severe CAP criteria (Major criteria: invasive mechanical ventilation, septic shock with need for vasopressors; Minor criteria: RR >= 30, PaO2/FiO2 <= 250, multilobar infiltrates, confusion/disorientation, uremia [BUN >= 20 mg/dL], leukopenia [WBC < 4000/uL], thrombocytopenia [platelets < 100,000/uL], hypothermia [core temp < 36°C], hypotension requiring aggressive fluid resuscitation); Severe CAP defined by 1 major or >= 3 minor criteria
  • •Epidemiological exposures: Cigarette smoking, structural lung disease, alcoholism, travel history, livestock/zoonotic exposure, and exposure to cooling towers (Legionella pneumophila)

🩺 معاینه فیزیکی (Physical Exam):

  • •Vital signs & mental status: Core body temperature > 39.0°C or hypothermia < 36.0°C (poor prognostic sign in elderly), severe tachypnea (RR > 30-35 breaths/min), tachycardia, hypotension (MAP < 65 mmHg), and new acute confusion or delirium
  • •Consolidation signs: Dullness to percussion over affected pulmonary segments, increased tactile and vocal fremitus, bronchial breath sounds, egophony ('E' to 'A' change), whispered pectoriloquy, and coarse inspiratory crackles
  • •Extrapulmonary clues: Severe diarrhea, confusion, and hyponatremia suggesting Legionella pneumophila; cold agglutinin autoimmune hemolysis or bullous myringitis suggesting Mycoplasma pneumoniae; cutaneous petechiae or purpura suggesting overwhelming pneumococcal or meningococcal bacteremia

🧪 آزمایشگاه و تصویربرداری:

  • •Chest Radiography & Thoracic CT: Multilobar or bilateral alveolar consolidations, dense lobar air bronchograms, cavitation (suggesting Staphylococcus aureus or Klebsiella pneumoniae), and parapneumonic pleural effusions
  • •Microbiological Testing: Blood cultures (2 sets from distinct venipuncture sites before antibiotics); expectorated or endotracheal aspirate sputum Gram stain and culture; urinary antigen tests for Streptococcus pneumoniae and Legionella pneumophila serogroup 1; multiplex PCR for viral respiratory pathogens (influenza A/B, SARS-CoV-2, RSV)
  • •Laboratory Biomarkers: Complete blood count (marked leukocytosis with bandemia > 10% or severe leukopenia < 4000/uL), serum procalcitonin (typically > 0.5-2.0 mcg/L in severe bacterial CAP), C-reactive protein (CRP > 150-200 mg/L), comprehensive metabolic panel (BUN, creatinine, electrolytes [hyponatremia]), arterial blood gas (hypoxemia, PaO2/FiO2 <= 250 mmHg), and serum lactate

💊 دستورات بستری و درمانی (Generic INN):

  • ✓Diet/Activity: Strict NPO during initial resuscitation and respiratory distress; bed rest in semi-Fowler position (30-45 degrees elevation) to minimize aspiration risk; early mobilization protocol as clinical stability improves
  • ✓Monitoring: Continuous pulse oximetry, continuous arterial line blood pressure monitoring if in septic shock, hourly urine output via Foley catheter (target > 0.5 mL/kg/hr), serial lactate measurements every 2-4 hours until normalized, and repeat chest radiograph in 48-72 hours or if clinical deterioration
  • ✓IV Hydration: Intravenous crystalloid fluid resuscitation with Lactated Ringer's or 0.9% Normal Saline at 30 mL/kg within the first 3 hours for sepsis-induced hypoperfusion or septic shock; subsequent fluid titration guided by dynamic measures of fluid responsiveness (passive leg raise, stroke volume variation)
  • ✓Pharmacotherapy (Generic Only): EMPIRIC ANTIMICROBIAL THERAPY (Initiate within 1 hour of diagnosis): Ceftriaxone 2 g IV every 24 hours (or Ampicillin-Sulbactam 3 g IV every 6 hours) PLUS Azithromycin 500 mg IV every 24 hours OR Levofloxacin 750 mg IV every 24 hours (or Moxifloxacin 400 mg IV every 24 hours); IF RISK FACTORS FOR PSEUDOMONAS AERUGINOSA: Piperacillin-Tazobactam 4.5 g IV every 6 hours (extended 4-hour infusion) OR Cefepime 2 g IV every 8 hours OR Meropenem 1 g IV every 8 hours PLUS Levofloxacin 750 mg IV every 24 hours; IF RISK FACTORS FOR METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA): Add Vancomycin 15-20 mg/kg IV every 8-12 hours (target AUC/MIC 400-600 or trough 15-20 mcg/mL) OR Linezolid 600 mg IV every 12 hours; SYSTEMIC ADJUNCTIVE CORTICOSTEROIDS (in severe CAP with refractory shock, CAPE COD trial): Hydrocortisone 200 mg/day IV continuous infusion (or 50 mg IV every 6 hours) for 4-8 days; VASOPRESSOR SUPPORT (for septic shock): Norepinephrine 0.05-0.5 mcg/kg/min IV continuous infusion titrated to target MAP >= 65 mmHg; VTE PROPHYLAXIS: Enoxaparin 40 mg subcutaneous once daily

⚠️ علائم خطر حیات (Red Flags):

  • !Rapid progression to refractory septic shock requiring escalating high-dose dual vasopressors (Norepinephrine plus Vasopressin)
  • !Acute development of ARDS (PaO2/FiO2 <= 100 mmHg) with progressive bilateral alveolar opacities requiring urgent lung-protective mechanical ventilation
  • !Development of massive complicated parapneumonic effusion or pleural empyema with mediastinal shift requiring emergent chest tube thoracostomy

پنومونی بیمارستانی و پنومونی وابسته به ونتیلاتور (HAP/VAP)

(Hospital-Acquired & Ventilator-Associated Pneumonia (HAP / VAP))
ICD-10: J95.851مرجع: Murray & Nadel's Textbook of Respiratory Medicine - Ch. 35

📋 نکات شرح حال (History Pearls):

  • •Clinical onset timeline: Development of new lower respiratory tract infection symptoms occurring >= 48 hours after hospital admission (HAP) or >= 48 hours following endotracheal intubation and mechanical ventilation (VAP)
  • •Patient vulnerability & risk factors: Prior intravenous antimicrobial therapy within past 90 days, prolonged ICU stay (> 5 days), structural lung disease, re-intubation, continuous enteral tube feeding with supine positioning, and tracheostomy
  • •Multidrug-Resistant (MDR) pathogen risk: Known hospital unit colonization rates > 20% for MRSA or Pseudomonas aeruginosa, septic shock at the time of VAP presentation, and acute renal replacement therapy prior to VAP onset

🩺 معاینه فیزیکی (Physical Exam):

  • •Ventilator & respiratory mechanics changes: Acute increase in minute ventilation requirements, acute rise in peak and plateau inspiratory airway pressures, deterioration in static pulmonary compliance, and worsening PaO2/FiO2 ratio requiring escalated FiO2 and PEEP
  • •Endotracheal secretions & auscultation: Abundant, new-onset purulent, thick, malodorous endotracheal or tracheobronchial secretions; localized coarse inspiratory rales, rhonchi, and bronchial breath sounds
  • •Systemic inflammatory signs: Core body temperature > 38.3°C or hypothermia < 36.0°C, resting tachycardia, and hemodynamic instability (hypotension, vasopressor escalation)

🧪 آزمایشگاه و تصویربرداری:

  • •Chest Radiography & Portable Imaging: New or progressive, persistent pulmonary infiltrate, consolidation, or cavitation on serial portable chest radiographs
  • •Quantitative / Semi-quantitative Lower Respiratory Cultures: Endotracheal aspirate (ETA, threshold >= 10^5 CFU/mL), Bronchoalveolar Lavage (BAL, threshold >= 10^4 CFU/mL), or protected specimen brush (PSB, threshold >= 10^3 CFU/mL) obtained prior to modifying antimicrobials; perform immediate Gram stain
  • •Laboratory & Biomarker Kinetics: Marked leukocytosis (WBC > 12,000/uL) or severe leukopenia (WBC < 4000/uL) with left shift; rising serum procalcitonin and C-reactive protein; serial blood cultures; arterial blood gas demonstrating acute hypoxemic gas exchange failure

💊 دستورات بستری و درمانی (Generic INN):

  • ✓Diet/Activity: Semi-recumbent positioning with head of bed elevated 30-45 degrees at all times to prevent microaspiration of contaminated gastric contents; pause enteral feeds and assess gastric residuals if prone positioning required; strict oral care with sterile water or chlorhexidine swabs every 4-6 hours
  • ✓Monitoring: Continuous pulse oximetry, continuous arterial line blood pressure monitoring, continuous capnography, hourly ventilator mechanics logging (plateau pressure, driving pressure, auto-PEEP), endotracheal tube cuff pressure monitoring maintained strictly at 20-30 cmH2O, and daily spontaneous breathing trial (SBT) readiness assessment
  • ✓IV Hydration: Targeted isotonic crystalloid therapy (0.9% Normal Saline or Lactated Ringer's) titrated to maintain euvolemia, central venous oxygen saturation (ScvO2 > 70%), and urine output > 0.5 mL/kg/hr; avoid positive fluid balance which worsens VAP-associated lung injury
  • ✓Pharmacotherapy (Generic Only): EMPIRIC BROAD-SPECTRUM ANTIMICROBIAL REGIMEN (Must cover MRSA and 2 antipseudomonal agents if MDR risk): ANTIPSEUDOMONAL BETA-LACTAM: Piperacillin-Tazobactam 4.5 g IV every 6 hours (extended 4-hour infusion) OR Cefepime 2 g IV every 8 hours (extended 4-hour infusion) OR Meropenem 1 g IV every 8 hours (extended 3-hour infusion; 2 g IV every 8 hours if high MIC); PLUS SECOND ANTIPSEUDOMONAL AGENT: Levofloxacin 750 mg IV every 24 hours OR Ciprofloxacin 400 mg IV every 8 hours OR Amikacin 15-20 mg/kg IV once daily (target peak 60 mcg/mL, trough < 5 mcg/mL); PLUS MRSA COVERAGE: Vancomycin 15-20 mg/kg IV every 8-12 hours (target AUC/MIC 400-600) OR Linezolid 600 mg IV every 12 hours; INHALED ANTIBIOTICS (Adjunct for resistant gram-negative pathogens): Inhaled Colistimethate Sodium (Colistin) 1-2 million international units nebulized every 8-12 hours OR Inhaled Amikacin 400-500 mg nebulized every 12 hours; VTE & STRESS ULCER PROPHYLAXIS: Enoxaparin 40 mg subcutaneous daily PLUS Pantoprazole 40 mg IV daily

⚠️ علائم خطر حیات (Red Flags):

  • !Ventilator failure with inability to maintain oxygenation (PaO2/FiO2 < 100 mmHg) and severe respiratory acidosis despite maximized ventilator settings
  • !Multidrug-resistant pathogen emergence (Carbapenem-Resistant Enterobacterales [CRE], Extensively Drug-Resistant [XDR] Acinetobacter baumannii, or Pan-Drug Resistant Pseudomonas aeruginosa) unresponsive to standard dual therapy
  • !Development of necrotizing pneumonia, lung abscess, or bronchopleural fistula presenting with massive air leaks through the chest drain and tension pneumothorax

پنوموتوراکس حاد خودبخودی و پنوموتوراکس فشاری (تنشن)

(Acute Spontaneous & Tension Pneumothorax)
ICD-10: J93.0مرجع: Murray & Nadel's Textbook of Respiratory Medicine - Ch. 81

📋 نکات شرح حال (History Pearls):

  • •Symptom characteristics: Sudden onset of sharp, unilateral, pleuritic chest pain exacerbated by breathing or coughing, followed immediately by acute dyspnea, tachypnea, and severe apprehension
  • •Patient phenotypes: Primary spontaneous pneumothorax (PSP) classically occurs in tall, thin young males (aged 15-34, low BMI) and active smokers due to subpleural apical bleb rupture; Secondary spontaneous pneumothorax (SSP) occurs in patients with underlying lung disease (COPD with bullae, cystic fibrosis, necrotizing pneumonia, tuberculosis, lymphangioleiomyomatosis)
  • •Progression to tension physiology: One-way valve mechanism allowing air entry into the pleural space during inspiration without exit during expiration, leading to massive intrapleural pressure accumulation, mediastinal compression, and obstructive shock

🩺 معاینه فیزیکی (Physical Exam):

  • •Classic tension triad: Progressive severe hypotension (obstructive shock), profound cyanosis/respiratory distress, and distended jugular veins (secondary to superior vena cava compression and impaired venous return)
  • •Thoracic examination: Marked hyperresonance to percussion over the affected hemithorax, dramatically diminished or absent breath sounds on the ipsilateral side, and asymmetric chest wall excursion (hyperexpanded, immobile hemithorax)
  • •Anatomical shifts: Contralateral tracheal deviation (trachea pushed away from the affected side; late finding), ipsilateral intercostal bulging, subcutaneous crepitus, and tachycardia (HR > 130-140 bpm)

🧪 آزمایشگاه و تصویربرداری:

  • •Clinical Diagnosis (EMERGENT): Tension pneumothorax is a CLINICAL DIAGNOSIS requiring immediate decompression; DO NOT delay life-saving needle decompression or tube thoracostomy to obtain a chest radiograph!
  • •Point-of-Care Ultrasound (POCUS): Absent lung sliding ('stratosphere' or 'barcode' sign on M-mode), absent B-lines, absent lung pulse, and identification of the pathognomonic 'lung point' (demarcating the boundary between normal sliding lung and pneumothorax)
  • •Standard Radiography & CT (Post-Decompression / Non-Tension): Erect inspiratory PA chest radiograph demonstrating visceral pleural line with absent peripheral bronchovascular markings; deep sulcus sign in supine position; thoracic CT is gold standard to detect apical bullae, blebs, and quantify pneumothorax volume

💊 دستورات بستری و درمانی (Generic INN):

  • ✓Diet/Activity: Strict NPO until stabilized and chest tube secured; bed rest in upright Fowler position; strictly avoid Valsalva maneuvers and positive-pressure ventilation before decompression
  • ✓Monitoring: Continuous pulse oximetry, continuous ECG telemetry, automated blood pressure every 2-5 minutes during acute resuscitation, continuous observation of chest tube water-seal chamber for persistent air leak or bubbling
  • ✓IV Hydration: 0.9% Normal Saline at 50-100 mL/hr; maintain peripheral IV access; avoid excessive volume loading as primary pathology is mechanical obstructive inflow impairment
  • ✓Pharmacotherapy (Generic Only): IMMEDIATE NEEDLE DECOMPRESSION (EMERGENCY RESCUE FOR TENSION): Emergent decompression with a 14-16 gauge large-bore angiocatheter (minimum length 5-8 cm) inserted into the 2nd intercostal space at the midclavicular line OR the 4th/5th intercostal space at the anterior axillary line over the superior rib margin; DEFINITIVE TUBE THORACOSTOMY: Placement of a 24-28 French chest tube (for secondary or hemopneumothorax) or 10-14 French pigtail catheter (for primary spontaneous) connected to a water-seal drainage system with -20 cmH2O suction; ANALGESIA: Morphine 2-4 mg IV every 3-4 hours PRN (or Fentanyl 25-50 mcg IV) PLUS Paracetamol 1000 mg IV every 6 hours; LOCAL ANESTHESIA (Prior to chest tube): Lidocaine 1% or 2% (up to 3 mg/kg) infiltrated into the skin, subcutaneous tissue, intercostal muscles, and parietal pleura; CHEMICAL PLEURODESIS (for recurrent secondary pneumothorax or persistent leak): Doxycycline 500 mg or sterile Talc slurry 4-5 g suspended in 50 mL 0.9% Normal Saline instilled via chest tube

⚠️ علائم خطر حیات (Red Flags):

  • !Tension physiology with pulseless electrical activity (PEA) cardiac arrest requiring instant needle thoracostomy or emergent finger thoracostomy
  • !Persistent massive air leak ('bubbling during both inspiration and expiration') continuing > 48-72 hours, indicating a large bronchopleural fistula or major tracheobronchial tear requiring emergent thoracic surgical intervention
  • !Re-expansion pulmonary edema occurring following rapid evacuation of a chronic large pneumothorax (> 72 hours duration); presents with sudden cough, pink frothy sputum, and worsening hypoxemia

افیوژن پاراپنومونیک کمپلیکه و امپیم ریوی

(Complicated Parapneumonic Effusion & Thoracic Empyema)
ICD-10: J86.9مرجع: Murray & Nadel's Textbook of Respiratory Medicine - Ch. 80

📋 نکات شرح حال (History Pearls):

  • •Clinical course & failure to improve: Persistent or recrudescent high swinging fevers, drenching night sweats, weight loss, pleuritic chest pain, and non-resolving pneumonia despite 48-72 hours of appropriate antimicrobial therapy
  • •Three progressive pathophysiological stages: Exudative stage (uncomplicated parapneumonic effusion; sterile fluid, normal pH); Fibrinopurulent stage (complicated effusion; bacterial invasion, fibrin deposition, septation, loculation); Organizing stage (chronic empyema; thick pleural peel, lung entrapment, restricted chest wall dynamics)
  • •Predisposing factors: Poor dentition/periodontal disease (aspiration of anaerobic oral flora), alcoholism, gastroesophageal reflux, seizure disorders, diabetes mellitus, malnutrition, and thoracic trauma or instrumentation

🩺 معاینه فیزیکی (Physical Exam):

  • •Thoracic percussion & auscultation: Stony dullness to percussion over the base of the involved hemithorax, severely diminished or absent vesicular breath sounds, absent tactile and vocal fremitus, with bronchial breath sounds and egophony immediately above the effusion line
  • •Signs of sepsis & chronicity: High remittent fever, tachycardia, cachexia, digital clubbing (in chronic organizing empyema), and splinting of the affected hemithorax with decreased ipsilateral excursion
  • •Empyema necessitans: Swelling, erythema, warmth, and fluctuation over the chest wall indicating spontaneous dissecting tracking of pleural pus through the parietal pleura and intercostal space into the subcutaneous tissue

🧪 آزمایشگاه و تصویربرداری:

  • •Diagnostic Thoracentesis (Pleural Fluid Analysis - Crucial Criteria): Grossly purulent fluid, foul odor (pathognomonic of anaerobes); complicated effusion defined by pleural fluid pH < 7.20, pleural fluid glucose < 60 mg/dL (< 3.3 mmol/L), and elevated pleural fluid lactate dehydrogenase (LDH > 1000 IU/L); positive pleural fluid Gram stain or bacterial culture confirms empyema
  • •Contrast-Enhanced Chest CT: Delineates loculations, thickened enhancing parietal and visceral pleural layers creating the classic 'split pleura sign', pleural microbubbles of gas, underlying pulmonary abscess, and aids image-guided catheter placement
  • •Laboratory & Microbial Evaluation: Complete blood count (marked leukocytosis with prominent neutrophilia), elevated ESR and CRP, serial blood cultures, and pleural fluid PCR for fastidious pathogens

💊 دستورات بستری و درمانی (Generic INN):

  • ✓Diet/Activity: High-calorie, high-protein oral diet to combat profound catabolism once stable; bed rest in semi-Fowler position, encouraging patient to lie on the affected side to optimize ventilation-perfusion matching in the healthy contralateral lung
  • ✓Monitoring: Continuous pulse oximetry, daily chest radiography or bedside thoracic ultrasound to evaluate fluid drainage and loculation resolution, continuous monitoring of chest tube output volume and character, serial temperature and inflammatory marker (CRP) tracking
  • ✓IV Hydration: Intravenous maintenance with 0.9% Normal Saline or Lactated Ringer's at 75-100 mL/hr to maintain hydration and replace ongoing exudative proteinaceous losses
  • ✓Pharmacotherapy (Generic Only): EMPIRIC SYSTEMIC ANTIMICROBIALS (Must cover Streptococcus pneumoniae, MSSA/MRSA, Gram-negative bacilli, and oral anaerobes): Piperacillin-Tazobactam 4.5 g IV every 6 hours (or Meropenem 1 g IV every 8 hours) OR Ceftriaxone 2 g IV every 24 hours PLUS Metronidazole 500 mg IV every 8 hours (or Ampicillin-Sulbactam 3 g IV every 6 hours); add Vancomycin 15-20 mg/kg IV every 8-12 hours if MRSA is suspected; continue IV therapy for 2-4 weeks; TUBE THORACOSTOMY & DRAINAGE: Immediate complete drainage of complicated effusion or empyema via a 14-24 French chest tube placed under ultrasound or CT guidance; INTRAPLEURAL FIBRINOLYTIC & ENZYMATIC THERAPY (MIST-2 Protocol for loculated empyema): Alteplase (Tissue Plasminogen Activator) 10 mg PLUS Dornase Alfa (DNase) 5 mg instilled intrapleurally twice daily for 3 consecutive days (6 doses total), each followed by clamping the chest tube for 2 hours before releasing to suction; SURGICAL INTERVENTION (VATS): Video-Assisted Thoracoscopic Surgery (VATS) debridement or open decortication if tube drainage and intrapleural fibrinolytics fail to achieve lung re-expansion within 7-10 days

⚠️ علائم خطر حیات (Red Flags):

  • !Development of bronchopleural fistula presenting with sudden expectoration of large quantities of purulent pleural fluid, sudden coughing spasm, and massive pneumothorax
  • !Septic shock refractory to volume resuscitation requiring intensive care admission, central line placement, and Norepinephrine infusion
  • !Fibrothorax with severe lung entrapment and trapped lung syndrome causing chronic ventilatory restriction requiring radical open thoracotomy decortication

سندرم خونریزی حاد منتشر آلوئولار (DAH)

(Acute Diffuse Alveolar Hemorrhage Syndrome (DAH))
ICD-10: M31.0مرجع: Murray & Nadel's Textbook of Respiratory Medicine - Ch. 63

📋 نکات شرح حال (History Pearls):

  • •Clinical triad & presentation: Acute onset of dyspnea, progressive hypoxemia, diffuse alveolar infiltrates on chest imaging, and hemoptysis (NOTE: frank hemoptysis is completely absent in up to 33% of patients with confirmed DAH because blood remains sequestered within the alveoli)
  • •Underlying autoimmune & systemic etiologies: Anti-Glomerular Basement Membrane disease (Goodpasture disease), ANCA-associated vasculitides (Granulomatosis with Polyangiitis [GPA], Microscopic Polyangiitis [MPA]), Systemic Lupus Erythematosus (SLE), antiphospholipid syndrome, allogeneic hematopoietic stem cell transplantation, crack cocaine inhalation, and direct drug toxicity (anticoagulants, propylthiouracil)
  • •Preceding constitutional & organ symptoms: Arthralgias, purpuric skin rashes, epistaxis, sinus pain, hematuria, oliguria, foamy urine (nephritic syndrome), fever, and profound fatigue

🩺 معاینه فیزیکی (Physical Exam):

  • •Respiratory distress & auscultation: Severe tachypnea, resting hypoxemia, intercostal retractions, and diffuse bilateral inspiratory crackles and rhonchi auscultated over the lower and mid-lung fields
  • •Vasculitic & systemic physical signs: Palpable purpura, livedo reticularis, digital ischemia/gangrene, episcleritis, uveitis, saddle-nose deformity, or nasal septal perforation (GPA)
  • •Anemia & hemodynamic markers: Severe pallor, resting tachycardia, orthostatic hypotension or hypertension secondary to acute glomerulonephritis, and peripheral edema

🧪 آزمایشگاه و تصویربرداری:

  • •Flexible Bronchoscopy with Serial Bronchoalveolar Lavage (BAL - GOLD STANDARD): Diagnostic confirmation requires serial sequential aliquots of 20-50 mL saline instilled into a wedged pulmonary segment showing progressively bloodier returns (aliquot 3 is darker red/hemorrhagic than aliquot 1); cytology demonstrates >= 20% hemosiderin-laden macrophages (siderophages) on Prussian blue stain
  • •High-Resolution CT & Pulmonary Function: Bilateral diffuse ground-glass opacities, air-space consolidation, and 'crazy-paving' pattern with sparing of the extreme apices and subpleural spaces; marked acute elevation of carbon monoxide diffusing capacity (DLCO > 100-130% of baseline) due to intra-alveolar hemoglobin binding of inhaled CO
  • •Serological & Renal Panel: Antineutrophil cytoplasmic antibodies (c-ANCA / PR3, p-ANCA / MPO), anti-GBM antibodies, antinuclear antibodies (ANA), anti-double-stranded DNA (anti-dsDNA), serum complement (C3, C4), urinalysis (dysmorphic red blood cells, red blood cell casts, proteinuria), and rising BUN/creatinine

💊 دستورات بستری و درمانی (Generic INN):

  • ✓Diet/Activity: Strict NPO during active hemoptysis and acute respiratory failure; bed rest in semi-Fowler position; maintain absolute airway protection
  • ✓Monitoring: Continuous arterial line blood pressure monitoring, continuous pulse oximetry, serial ABG measurements, strict hourly urine output via Foley catheter (monitor for acute glomerulonephritis / oliguria), serial hemoglobin/hematocrit every 4-6 hours
  • ✓IV Hydration: Cautious crystalloid infusion with 0.9% Normal Saline at 50-75 mL/hr; avoid aggressive fluid loading which increases pulmonary microvascular hydrostatic pressure and exacerbates alveolar flooding; transfuse Packed Red Blood Cells to maintain hemoglobin >= 8-9 g/dL
  • ✓Pharmacotherapy (Generic Only): HIGH-DOSE PULSE CORTICOSTEROIDS (Immediate First-Line): Methylprednisolone 1000 mg (1 g) IV daily for 3 consecutive days, followed by oral Prednisone 1 mg/kg/day; IMMUNOSUPPRESSIVE INDUCTION THERAPY (for ANCA vasculitis or SLE): Cyclophosphamide 10-15 mg/kg IV every 2-3 weeks (or 2 mg/kg/day orally adjusted for renal function) PLUS Mesna for uroprotection; OR Rituximab 375 mg/m2 IV once weekly for 4 weeks (or 1000 mg IV on days 1 and 15); THERAPEUTIC PLASMA EXCHANGE (PLEX / Plasmapheresis): Strongly indicated for anti-GBM disease (Goodpasture) and severe DAH secondary to ANCA vasculitis with rapidly progressive glomerulonephritis (7-14 daily or alternate-day 4-liter exchanges using 5% Albumin and fresh frozen plasma); PROPHYLACTIC REGIMENS: Trimethoprim-Sulfamethoxazole 160/800 mg orally 3 times weekly (for Pneumocystis jirovecii prophylaxis during immunosuppression) PLUS Pantoprazole 40 mg IV daily for gastroprotection; MECHANICAL VENTILATION (if required for respiratory failure): Low tidal volume lung-protective ventilation (6 mL/kg), high PEEP (10-15 cmH2O) to exert a mechanical tamponade effect on alveolar capillaries, avoiding excessive peak pressures

⚠️ علائم خطر حیات (Red Flags):

  • !Catastrophic asphyxiation secondary to massive flooding of the tracheobronchial tree with blood, requiring emergent single-lung isolation or dual-lumen intubation
  • !Rapidly progressive glomerulonephritis with anuria and accelerated uremia requiring urgent emergency hemodialysis
  • !Severe secondary pulmonary superinfection (Pneumocystis jirovecii, Aspergillus, CMV) emerging during aggressive pulse immunosuppressive therapy

تشدید حاد فیبروز ریوی ایدیوپاتیک (AE-IPF)

(Acute Exacerbation of Idiopathic Pulmonary Fibrosis (AE-IPF))
ICD-10: J84.112مرجع: Murray & Nadel's Textbook of Respiratory Medicine - Ch. 60

📋 نکات شرح حال (History Pearls):

  • •Diagnostic criteria (Collard / ATS/ERS/JRS/ALAT criteria): Acute worsening of dyspnea and hypoxemia developing over <= 1 month in a patient with established or newly diagnosed idiopathic pulmonary fibrosis (IPF) / Usual Interstitial Pneumonia (UIP) pattern
  • •Exclusionary conditions: Must exclude alternative identifiable causes of rapid deterioration: congestive heart failure / left ventricular systolic dysfunction, acute pulmonary thromboembolism, pneumothorax, and fluid overload
  • •High-risk precipitating triggers: Often idiopathic (spontaneous), but frequently triggered by microaspiration of gastric contents, recent thoracic surgical lung biopsy or bronchoscopy, viral respiratory tract infection, or environmental pollutants

🩺 معاینه فیزیکی (Physical Exam):

  • •Auscultatory hallmarks: Bilateral diffuse fine end-inspiratory 'Velcro-like' crackles predominantly in the lung bases and axillae, persisting after coughing; profound tachypnea (RR > 30-35 breaths/min)
  • •Signs of advanced chronicity & severe hypoxemia: Digital clubbing (present in > 50-70% of IPF patients), central cyanosis, profound oxygen desaturation with minimal exertion or speech
  • •Cor pulmonale & pulmonary hypertension: Prominent jugular venous distention with giant v-waves, loud pulmonic valve closure sound (P2), tricuspid regurgitant murmur, right ventricular heave, and peripheral edema

🧪 آزمایشگاه و تصویربرداری:

  • •High-Resolution CT (HRCT - CRITICAL): New bilateral ground-glass opacities and/or consolidation superimposed on the pre-existing background of peripheral, subpleural, basal-predominant UIP pattern (reticulation, honeycombing, traction bronchiectasis)
  • •Arterial Blood Gas (ABG): Severe acute-on-chronic hypoxemic respiratory failure (PaO2 markedly decreased, widening of the alveolar-arterial oxygen gradient, often PaO2/FiO2 < 200 mmHg), typically with respiratory alkalosis or normal PaCO2 until terminal exhaustion
  • •Bronchoalveolar Lavage (BAL) & Infection Exclusion: BAL to rule out active opportunistic pulmonary infections (stains and cultures for bacteria, fungi, mycobacteria, Pneumocystis jirovecii, and viral multiplex PCR); differential cell count shows marked neutrophilia and lymphocytosis

💊 دستورات بستری و درمانی (Generic INN):

  • ✓Diet/Activity: Strict NPO during severe dyspneic crisis; bed rest with head elevated 45 degrees; patient comfort care and early palliative goal-of-care alignment discussions given high hospital mortality (> 50-80%)
  • ✓Monitoring: Continuous pulse oximetry, continuous arterial line monitoring for arterial blood gases, continuous cardiac telemetry for supraventricular arrhythmias, hourly fluid balance
  • ✓IV Hydration: Conservative fluid management: 0.9% Normal Saline at 30-50 mL/hr; strictly avoid fluid overload which exacerbates diffuse alveolar damage and accelerates respiratory failure
  • ✓Pharmacotherapy (Generic Only): HIGH-DOSE SYSTEMIC CORTICOSTEROIDS (Empiric Standard of Care): Methylprednisolone 500-1000 mg IV daily for 3 consecutive days, followed by oral Prednisone 1 mg/kg/day with slow taper over 4-8 weeks; EMPIRIC BROAD-SPECTRUM ANTIMICROBIALS (Pending microbiological exclusion): Piperacillin-Tazobactam 4.5 g IV every 6 hours PLUS Levofloxacin 750 mg IV daily PLUS Azithromycin 500 mg IV daily (to treat occult bacterial infection and atypical pathogens); PROPHYLAXIS: Trimethoprim-Sulfamethoxazole 160/800 mg orally 3 times weekly (for Pneumocystis jirovecii prophylaxis) PLUS Pantoprazole 40 mg IV daily; HIGH-FLOW NASAL CANNULA (HFNC): Preferred noninvasive oxygen delivery modality (flow 40-60 L/min, FiO2 titrated to SpO2 88-92%) to avoid patient-ventilator barotrauma and patient-self-inflicted lung injury (P-SILI); AVOID INVASIVE MECHANICAL VENTILATION (unless bridge to emergent lung transplant): Invasive mechanical ventilation is associated with > 90% in-hospital mortality due to ventilator-induced barotrauma in stiff, fibrotic lungs

⚠️ علائم خطر حیات (Red Flags):

  • !Refractory hypoxemic respiratory failure unresponsive to HFNC and high FiO2 (terminal respiratory failure)
  • !Development of barotrauma: Pneumothorax or pneumomediastinum secondary to rupture of honeycombed subpleural cysts under positive airway pressure
  • !Rapid hemodynamic collapse secondary to acute right ventricular decompensation (acute cor pulmonale)

سندرم هیپوونتیلاسیون چاقی شدید (سندرم پیک‌ویکین)

(Severe Obesity Hypoventilation Syndrome (OHS / Pickwickian Syndrome))
ICD-10: E66.2مرجع: Murray & Nadel's Textbook of Respiratory Medicine - Ch. 99

📋 نکات شرح حال (History Pearls):

  • •Classic clinical diagnostic triad: Body Mass Index (BMI) >= 30 kg/m2 (frequently >= 40-50 kg/m2), daytime awake chronic alveolar hypoventilation (arterial PaCO2 >= 45 mmHg), and absence of an alternative primary cause of hypoventilation (severe COPD, neuromuscular disease, thoracic cage deformities)
  • •Associated sleep-disordered breathing symptoms: Severe loud chronic snoring, witnessed apneas, choking or gasping arousals, excessive daytime sleepiness (Epworth Sleepiness Scale score > 15), morning retro-orbital headaches (from nocturnal hypercapnic cerebral vasodilation), and cognitive slowing
  • •Acute-on-chronic decompensation triggers: Administration of sedatives, opioids, or benzodiazepines; acute upper or lower respiratory viral/bacterial infections; supplemental oxygen administration without ventilatory support; or post-anesthesia emergence

🩺 معاینه فیزیکی (Physical Exam):

  • •Habitus & upper airway anatomy: Massive central/morbid obesity, large neck circumference (> 17 inches / 43 cm in men, > 16 inches / 40 cm in women), crowded oropharynx (Mallampati class IV, enlarged uvula, hypertrophic tonsils, low-hanging soft palate)
  • •Respiratory mechanics & auscultation: Shallow rapid breathing pattern, muffled breath sounds secondary to thick chest wall adipose tissue, bibasilar atelectatic crackles that clear with deep inspiration, and reduced chest wall compliance
  • •Right ventricular failure & pulmonary hypertension signs: Plethoric facial flushing, conjunctival suffusion, engorged non-collapsing jugular veins, loud P2, right ventricular heave, tender hepatomegaly, and massive brawny pitting lower extremity edema extending to thighs and abdominal wall

🧪 آزمایشگاه و تصویربرداری:

  • •Arterial Blood Gas (ABG): Chronic compensated or acute-on-chronic respiratory acidosis (elevated PaCO2 >= 45 mmHg, compensatory elevated serum bicarbonate HCO3- >= 27 mEq/L, low PaO2); marked base excess indicates chronic renal retention of bicarbonate
  • •Polysomnography (Sleep Study): Severe obstructive sleep apnea (Apnea-Hypopnea Index [AHI] > 30 events/hr) present in ~90% of OHS patients, with sustained prolonged nocturnal oxygen desaturations (< 80-85%) not explained by discrete apneas alone (sustained sleep hypoventilation)
  • •Paraclinical Corroboration: Serum venous bicarbonate (screening cutoff HCO3- >= 27 mEq/L has 92% sensitivity for OHS); Complete blood count demonstrating secondary erythrocytosis (hematocrit > 50-55% from chronic nocturnal hypoxemia); Transthoracic echocardiography demonstrating right ventricular hypertrophy, right ventricular dilation, and pulmonary hypertension (elevated pulmonary artery systolic pressure > 40-50 mmHg)

💊 دستورات بستری و درمانی (Generic INN):

  • ✓Diet/Activity: Caloric restriction and medically supervised weight loss program once acute crisis resolves; head of bed elevated 30-45 degrees or reverse Trendelenburg positioning to relieve diaphragmatic cephalad compression by abdominal pannus; avoid all central nervous system depressants, sedatives, hypnotics, and opioids
  • ✓Monitoring: Continuous pulse oximetry, continuous transcutaneous or arterial PaCO2 monitoring, continuous cardiac telemetry for brady-tachyarrhythmias, daily weight measurements, and strict fluid intake and output monitoring
  • ✓IV Hydration: Conservative fluid management: 0.9% Normal Saline at 30-50 mL/hr; loop diuretic therapy with Furosemide 20-40 mg IV every 12 hours to treat peripheral edema and right heart overload, monitoring potassium and preventing metabolic alkalosis which blunts ventilatory drive
  • ✓Pharmacotherapy (Generic Only): NONINVASIVE POSITIVE PRESSURE VENTILATION (NIV / BiPAP - FIRST-LINE TREATMENT): Immediate initiation of Bilevel Positive Airway Pressure in spontaneous/timed (S/T) mode; initial settings: IPAP 16-20 cmH2O, EPAP 8-10 cmH2O (pressure support >= 8-10 cmH2O to overcome chest wall elastance and abolish upper airway obstruction), backup respiratory rate 12-14 breaths/min, titrated to normalize daytime PaCO2 and relieve hypoxemia; CONTROLLED OXYGEN THERAPY: Administer supplemental oxygen ONLY in conjunction with positive airway pressure, titrated to maintain SpO2 88-92% (uncontrolled high-flow oxygen suppresses peripheral hypoxic drive and precipitates fatal hypercapnic coma); RESPIRATORY STIMULANTS (Adjunctive/Reserve only): Acetazolamide 250 mg orally twice daily (induces renal bicarbonate excretion, creates metabolic acidosis, and stimulates central respiratory drive in patients with persistent severe metabolic alkalosis blunting ventilation); VTE PROPHYLAXIS: Enoxaparin 40 mg subcutaneous every 12 hours (dose adjusted for morbid obesity; or Heparin 5000 units subcutaneous every 8 hours)

⚠️ علائم خطر حیات (Red Flags):

  • !Administration of uncontrolled high-concentration oxygen resulting in rapid PaCO2 surge (> 80-100 mmHg), progressive somnolence, and hypercapnic respiratory arrest
  • !Severe difficult airway anatomy leading to 'cannot intubate, cannot oxygenate' crisis if emergent intubation is attempted without video laryngoscopy or awake fiberoptic setup
  • !Acute decompensated right ventricular failure with refractory anasarca, prerenal azotemia, and hepatic congestion

نارسایی حاد تنفسی هایپرکاپنیک تحت تهویه غیرتهاجمی (BiPAP)

(Acute Hypercapnic Respiratory Failure & Noninvasive Ventilation (BiPAP))
ICD-10: J96.02مرجع: Murray & Nadel's Textbook of Respiratory Medicine - Ch. 102

📋 نکات شرح حال (History Pearls):

  • •Pathophysiologic hallmark & symptoms: Imbalance between ventilatory demand and neuromuscular capacity leading to acute alveolar hypoventilation; acute dyspnea, progressive somnolence, morning headaches, confusion, restlessness, and lethargy
  • •Underlying causes: Severe COPD exacerbation, obesity hypoventilation, neuromuscular disorders (amyotrophic lateral sclerosis, Guillain-Barre syndrome, myasthenia gravis crisis), chest wall deformities (kyphoscoliosis), and respiratory depressant intoxications
  • •Pre-existing ventilatory reserve: Baseline functional capacity, prior BiPAP/CPAP adherence, history of tracheostomy, and duration of current symptomatic deterioration

🩺 معاینه فیزیکی (Physical Exam):

  • •Neurological & cognitive state: Hypercapnic encephalopathy: confusion, disorientation, lethargy, somnolence, asterixis (flapping tremor), myoclonus, and miosis or sluggish pupillary responses
  • •Respiratory pump mechanics: Severe tachypnea (RR > 30 breaths/min) or bradypnea (ominous sign of terminal respiratory center failure), shallow tidal excursions, abdominal paradox (inward movement during inspiration indicating diaphragmatic fatigue), and prominent scalene/sternocleidomastoid recruitment
  • •Hemodynamic manifestations: Sympathetic surge (tachycardia, diaphoresis, systemic hypertension) followed by peripheral vasodilation (warm bounding pulses, flushed skin) from direct CO2 vascular relaxation

🧪 آزمایشگاه و تصویربرداری:

  • •Arterial Blood Gas (ABG - Mandatory Baseline & Serial): Acute respiratory acidosis defined by pH < 7.35 and PaCO2 > 45 mmHg; acute-on-chronic failure distinguished by elevated calculated bicarbonate (HCO3- > 30 mEq/L) with base excess > +4 mEq/L
  • •Serial ABG Response to BiPAP: Repeat ABG at 1 hour and 2 hours following BiPAP initiation; failure of pH to improve or rise in PaCO2 after 1-2 hours is a strong predictor of NIV failure requiring endotracheal intubation
  • •Diagnostic Radiography & Electrolytes: Portable chest radiography (excludes untreated pneumothorax, large consolidation, or severe pulmonary edema); complete blood count; serum electrolytes (evaluates hypokalemia, hypophosphatemia, and hypomagnesemia which impair diaphragmatic muscle contractility)

💊 دستورات بستری و درمانی (Generic INN):

  • ✓Diet/Activity: Strict NPO during active noninvasive ventilation to eliminate aspiration risk; head of bed elevated >= 45 degrees; patient positioned comfortably with proper interface fitting (oronasal face mask or total face mask) to minimize air leaks without excessive facial skin pressure
  • ✓Monitoring: Continuous pulse oximetry, continuous ECG telemetry, repeat arterial blood gas at 30-60 minutes post-initiation and every 2 hours until acidosis resolves (pH > 7.35), continuous expired tidal volume monitoring (target Vte 6-8 mL/kg ideal body weight), and strict leak monitoring (< 20-30 L/min)
  • ✓IV Hydration: Intravenous maintenance with 0.9% Normal Saline or 5% Dextrose in 0.45% Saline at 50-75 mL/hr; maintain euvolemia; avoid volume overexpansion
  • ✓Pharmacotherapy (Generic Only): BILEVEL NONINVASIVE POSITIVE PRESSURE VENTILATION (BiPAP SETTINGS): Spontaneous/Timed (S/T) mode; initial Inspiratory Positive Airway Pressure (IPAP) 10-12 cmH2O, Expiratory Positive Airway Pressure (EPAP) 4-5 cmH2O, backup respiratory rate 12-14 breaths/min; titrate IPAP up by 2 cmH2O every 15-30 minutes (target IPAP 16-20 cmH2O) to achieve tidal volume 6-8 mL/kg and decrease respiratory rate < 25/min; titrate EPAP up to maintain upper airway patency and improve oxygenation; titrate FiO2 to maintain SpO2 88-92%; PHARMACOLOGIC BRONCHODILATION (via in-line nebulizer): Albuterol 2.5 mg nebulized every 2-4 hours PLUS Ipratropium Bromide 0.5 mg nebulized every 6 hours; REVERSAL AGENTS (if opioid or benzodiazepine-induced hypoventilation): Naloxone 0.04-0.4 mg IV (titrated cautiously to reverse hypoventilation without precipitating acute withdrawal) OR Flumazenil 0.2 mg IV (use with extreme caution, contraindicated in chronic benzodiazepine dependency or seizure history); GASTRIC DECOMPRESSION: Nasogastric tube on low intermittent suction if significant gastric insufflation occurs during positive pressure ventilation

⚠️ علائم خطر حیات (Red Flags):

  • !Absolute contraindications to continued NIV: Respiratory arrest, inability to protect the airway (loss of gag/cough reflex), copious unmanageable respiratory secretions, persistent vomiting, severe facial trauma/deformity, or hemodynamic instability (refractory shock)
  • !Failure of arterial blood gas to improve (persistent pH < 7.25 and rising PaCO2) or worsening mental status after 1-2 hours of optimal BiPAP, indicating need for prompt endotracheal intubation
  • !Mask-induced pressure necrosis, severe gastric distension with vomiting and massive pulmonary aspiration

تشدید حاد ریوی در فیبروز سیستیک (CF)

(Cystic Fibrosis Acute Pulmonary Exacerbation (CF Exacerbation))
ICD-10: E84.0مرجع: Murray & Nadel's Textbook of Respiratory Medicine - Ch. 48

📋 نکات شرح حال (History Pearls):

  • •Diagnostic criteria for pulmonary exacerbation (Fuchs criteria): Increased cough, change in sputum production (increased volume, viscosity, or darker purulence), new or increased hemoptysis, increased dyspnea, new fatigue/lethargy, anorexia or weight loss, and decrease in FEV1 >= 10% from baseline
  • •Age-dependent airway microbiology: Early childhood dominated by Staphylococcus aureus and Haemophilus influenzae; adolescence and adulthood dominated by chronic colonization with Pseudomonas aeruginosa (mucoid phenotype), Burkholderia cepacia complex, Stenotrophomonas maltophilia, and non-tuberculous mycobacteria (NTM)
  • •Pancreatic & systemic manifestations: Pancreatic exocrine insufficiency (steatorrhea, fat-soluble vitamin malabsorption), cystic fibrosis-related diabetes (CFRD), distal intestinal obstruction syndrome (DIOS), and prior pneumothorax or massive hemoptysis history

🩺 معاینه فیزیکی (Physical Exam):

  • •Thoracic examination & adventitious sounds: Hyperinflated barrel chest, intercostal and suprasternal retractions, coarse diffuse crackles, polyphonic expiratory wheezes, and scattered rhonchi that clear or shift with vigorous coughing
  • •Chronic physical stigmata: Severe digital clubbing (in almost 100% of adults with advanced CF), cachexia, temporal wasting, low BMI, and nasal polyposis on anterior rhinoscopy
  • •Sputum characteristics: Expectoration of copious, thick, tenacious, dark green or brown mucopurulent secretions, with or without blood-streaking

🧪 آزمایشگاه و تصویربرداری:

  • •Spirometry (Pulmonary Function Tests): Acute drop in FEV1, FVC, and FEF25-75% >= 10% compared to the patient's best baseline values within the previous 6 months; serves as primary objective metric for therapeutic response
  • •Quantitative Sputum Microbiology: Sputum Gram stain, selective media culture for Pseudomonas aeruginosa (isolating both mucoid and non-mucoid morphotypes), Burkholderia cepacia selective agar, acid-fast bacilli smear/culture, fungal culture (Aspergillus fumigatus), and extensive antimicrobial susceptibility testing (minimum inhibitory concentrations [MIC])
  • •Radiographic & Laboratory Evaluation: Chest radiograph (hyperinflation, cystic bronchiectasis, bronchial cuffing, mucus plugging, and new patchy consolidations); Complete blood count (leukocytosis); Serum electrolytes (hypochloremic metabolic alkalosis, hypokalemia from sweat losses); Blood glucose monitoring for CFRD exacerbation; and Serum IgG and total IgE with specific Aspergillus antibodies to exclude Allergic Bronchopulmonary Aspergillosis (ABPA)

💊 دستورات بستری و درمانی (Generic INN):

  • ✓Diet/Activity: High-calorie, high-protein, unrestricted fat diet (150-200% of recommended daily allowance); Pancreatic enzyme replacement therapy (Pancrelipase 2000-4000 lipase units/kg per meal, taken with first bite of food); Fat-soluble vitamin supplementation (Vitamins A, D, E, K); Active chest physiotherapy and airway clearance techniques (high-frequency chest wall oscillation vest, oscillating PEP device) 3-4 times daily
  • ✓Monitoring: Continuous pulse oximetry, daily spirometry (tracking FEV1 recovery), strict daily sputum volume and purulence logging, serum aminoglycoside peak and trough drug levels, serum creatinine and electrolytes every 48-72 hours
  • ✓IV Hydration: Intravenous 0.9% Normal Saline at 100-150 mL/hr to maintain optimal systemic hydration and decrease mucus viscoelasticity; liberal dietary salt supplementation (especially in warm environments or with fever)
  • ✓Pharmacotherapy (Generic Only): INTRAVENOUS DUAL ANTIMICROBIAL THERAPY (Targeting Pseudomonas aeruginosa; altered pharmacokinetics requiring higher doses and shorter intervals): AMINOGLYCOSIDE: Tobramycin 10-12 mg/kg IV once daily (target peak 20-30 mcg/mL, trough < 1 mcg/mL) OR Amikacin 30-35 mg/kg IV once daily; PLUS ANTIPSEUDOMONAL BETA-LACTAM: Ceftazidime 2 g IV every 8 hours (or Meropenem 2 g IV every 8 hours, or Piperacillin-Tazobactam 4.5 g IV every 6 hours extended infusion); MRSA COVERAGE (if documented colonization or culture): Vancomycin 15-20 mg/kg IV every 8-12 hours (target AUC/MIC 400-600) OR Linezolid 600 mg IV/oral every 12 hours; MUCOLYTIC & AIRWAY CLEARANCE PHARMACOTHERAPY: Dornase Alfa (Recombinant human DNase) 2.5 mg nebulized once or twice daily PLUS Hypertonic Saline 7% 4 mL nebulized twice daily (administered following Albuterol premedication); INHALED BRONCHODILATOR: Albuterol 2.5 mg nebulized 15 minutes before airway clearance and inhaled antibiotics; RESUME CFTR MODULATOR THERAPY: Continue patient's baseline CFTR modulator (e.g., Elexacaftor-Tezacaftor-Ivacaftor) throughout exacerbation unless severe hepatic impairment

⚠️ علائم خطر حیات (Red Flags):

  • !Massive hemoptysis (> 240 mL blood in 24 hours) requiring immediate cessation of chest physiotherapy, stopping hypertonic saline and dornase alfa, and emergent bronchial artery embolization
  • !Spontaneous pneumothorax secondary to ruptured subpleural bleb or bulla; manifests as sudden pleuritic chest pain and rapid deterioration, requiring urgent chest tube thoracostomy
  • !Aminoglycoside nephrotoxicity or ototoxicity (acute kidney injury, vestibular dysfunction, permanent sensorineural hearing loss)

عفونت حاد سوارشده بر برونشکتازی شدید

(Acute Severe Bronchiectasis Superinfection & Exacerbation)
ICD-10: J47.0مرجع: Murray & Nadel's Textbook of Respiratory Medicine - Ch. 49

📋 نکات شرح حال (History Pearls):

  • •Exacerbation definition (EMBARC / BTS Consensus Criteria): Deterioration in >= 3 key symptoms for >= 48 hours: increased cough frequency, increased sputum volume, increased sputum purulence/viscosity, new or worsening dyspnea, increased fatigue/malaise, and hemoptysis
  • •Underlying etiologies: Post-infectious (childhood pertussis, severe measles, tuberculosis), primary ciliary dyskinesia (Kartagener syndrome), common variable immunodeficiency (CVID) or hypogammaglobulinemia, alpha-1 antitrypsin deficiency, allergic bronchopulmonary aspergillosis (ABPA), and rheumatoid arthritis / Sjogren syndrome
  • •Exacerbation frequency: History of >= 3 exacerbations per year or prior chronic colonization with Pseudomonas aeruginosa identifies a high-risk phenotype with accelerated lung function decline and high mortality

🩺 معاینه فیزیکی (Physical Exam):

  • •Chest auscultation & adventitious sounds: Prominent coarse 'popping' crackles auscultated over the involved lung segments (predominantly lower lobes) during early and mid-inspiration, accompanied by expiratory polyphonic wheezes and harsh rhonchi that fluctuate after productive coughing
  • •Sputum layering: Expectoration of massive amounts of three-layered purulent sputum (top foamy frothy layer, middle clear serous layer, bottom thick sedimented purulent debris)
  • •Extrapulmonary physical signs: Digital clubbing (present in advanced structural bronchiectasis), halitosis, nasal polyposis, and signs of chronic cor pulmonale (elevated JVP, peripheral edema) in end-stage disease

🧪 آزمایشگاه و تصویربرداری:

  • •High-Resolution CT (HRCT - GOLD STANDARD FOR BRONCHIECTASIS): Demonstrates internal bronchial luminal diameter greater than the accompanying pulmonary artery branch (pathognomonic 'signet ring' sign), lack of normal bronchial tapering ('tram-track' sign), visualization of bronchi within 1 cm of the costal pleura, mucus impaction, and varicose or cystic clusters ('bunch of grapes')
  • •Sputum Microbiology & Resistance Profile: Gram stain and quantitative culture for bacterial pathogens: Haemophilus influenzae (most common in non-severe), Pseudomonas aeruginosa (marker of severe disease), Moraxella catarrhalis, Streptococcus pneumoniae, and non-tuberculous mycobacteria (Mycobacterium avium complex)
  • •Laboratory & Etiologic Workup: Complete blood count (leukocytosis, anemia of chronic disease), serum immunoglobulin quantification (IgG, IgA, IgM, IgG subclasses), total serum IgE and Aspergillus-specific IgE (to exclude ABPA), and baseline arterial blood gas

💊 دستورات بستری و درمانی (Generic INN):

  • ✓Diet/Activity: High-protein, nutrient-dense diet; bed rest in semi-Fowler position; postural drainage with active cycle of breathing techniques (ACBT) or oscillating positive expiratory pressure (O-PEP) device 3-4 times daily to mobilize inspissated secretions
  • ✓Monitoring: Continuous pulse oximetry, daily measurement of 24-hour expectorated sputum volume (target progressive reduction), serial temperature tracking, monitoring for hemoptysis, and weekly renal function/electrolyte panels
  • ✓IV Hydration: Intravenous crystalloid infusion with 0.9% Normal Saline at 75-100 mL/hr to maintain adequate systemic hydration, decrease sputum viscosity, and facilitate airway clearance
  • ✓Pharmacotherapy (Generic Only): EMPIRIC ANTIMICROBIAL THERAPY (Directed by prior sputum microbiology; 14-day duration standard): If NO prior Pseudomonas colonization: Amoxicillin-Clavulanate 875/125 mg orally every 8 hours OR Cefepime 2 g IV every 12 hours OR Levofloxacin 500-750 mg orally/IV daily; If PRIOR PSEUDOMONAS AERUGINOSA COLONIZATION OR SEVERE EXACERBATION: Piperacillin-Tazobactam 4.5 g IV every 6 hours (extended infusion) OR Ceftazidime 2 g IV every 8 hours PLUS Tobramycin 5-7 mg/kg IV once daily (or Ciprofloxacin 400 mg IV every 8-12 hours / 750 mg orally every 12 hours); AIRWAY HYDRATION & CLEARANCE PHARMACOTHERAPY: Nebulized Hypertonic Saline 3% or 7% 4 mL twice daily (induces osmotic hydration of airway surface liquid; premedicate with bronchodilator); INHALED BRONCHODILATOR: Albuterol 2.5 mg nebulized every 4-6 hours PRN to prevent hypertonic saline-induced bronchospasm; VTE PROPHYLAXIS: Enoxaparin 40 mg subcutaneous once daily

⚠️ علائم خطر حیات (Red Flags):

  • !Massive hemoptysis (> 200-300 mL within 24 hours) originating from hypertrophied, friable bronchial arteries, requiring emergent intervention
  • !Acute respiratory failure requiring noninvasive ventilation (BiPAP) or endotracheal intubation secondary to extensive bilateral mucus plugging and exhaustion
  • !Superinfection with highly resistant pathogens (Burkholderia cepacia, Multi-Drug Resistant Pseudomonas, or Mycobacterium abscessus) leading to rapid lung parenchymal destruction

هموپتیزی ماسیو و کاتاستروفیک ریوی

(Massive & Catastrophic Pulmonary Hemoptysis)
ICD-10: R04.2مرجع: Murray & Nadel's Textbook of Respiratory Medicine - Ch. 27

📋 نکات شرح حال (History Pearls):

  • •Hemoptysis volume & rate criteria: Expectoration of >= 100-200 mL of pure blood in a single episode or >= 400-600 mL over a 24-hour period (primary clinical threat is ASPHYXIATION and airway flooding rather than exsanguination; the anatomic pulmonary dead space is only ~150 mL)
  • •Underlying etiologies: Bronchiectasis (most common in Western nations; hypertrophied bronchial circulation), active cavitary pulmonary tuberculosis or mycetoma/aspergilloma (Rasmussen aneurysm), necrotizing pneumonia / lung abscess, bronchogenic carcinoma invading major pulmonary vessels, arterio-venous malformations, and thoracic aortic aneurysm rupture
  • •Coagulation & medication history: Anticoagulant use (Heparin, Warfarin, Apixaban, Rivaroxaban), antiplatelet agents, underlying cirrhosis/coagulopathy, or thrombocytopenia

🩺 معاینه فیزیکی (Physical Exam):

  • •Airway & respiratory distress signs: Severe air hunger, choking sensation, gasping, coughing spasms, inability to clear the airway, gurgling breath sounds over the chest, profound tachypnea, and cyanosis
  • •Hemodynamic & perfusion state: Profuse diaphoresis, resting tachycardia (HR > 120 bpm), orthostatic hypotension progressing to frank hypovolemic/hemorrhagic shock (SBP < 90 mmHg)
  • •Lateralization of bleeding source: Asymmetric auscultatory findings (unilateral bubbling rhonchi, localized coarse crackles, or dullness over the affected hemithorax indicating blood accumulation); distinguish from upper airway epistaxis (inspect oropharynx) and hematemesis (vomited acidic coffee-ground or dark blood with food particles)

🧪 آزمایشگاه و تصویربرداری:

  • •Emergent Bedside Flexible & Rigid Bronchoscopy: Definitive diagnostic and therapeutic procedure; directly localizes the bleeding segment, clears obstructing blood clots, enables topical vasoconstrictor application, balloon catheter tamponade, or cold saline lavage; rigid bronchoscopy provides superior suctioning capacity and airway control
  • •Multidetector CT Angiography (CT Chest with IV Contrast): Crucial study (if patient is hemodynamically stable) identifying the precise source of bleeding, delineating tortuous bronchial arteries (responsible for 90% of massive hemoptysis) or aberrant systemic non-bronchial systemic collaterals, and mapping anatomy prior to urgent embolization
  • •Coagulation & Laboratory Profile: Complete blood count (rapid assessment of hematocrit/hemoglobin, platelet count), PT, aPTT, INR, fibrinogen level, type and screen with crossmatch for 4-6 units of packed red blood cells, and arterial blood gas

💊 دستورات بستری و درمانی (Generic INN):

  • ✓Diet/Activity: Strict NPO; absolute bed rest; POSITIONING (LIFE-SAVING): Place patient in the DECUBITUS POSITION WITH THE BLEEDING LUNG DEPENDENT (bleeding side DOWN) to prevent blood from spilling over into the non-bleeding healthy lung and causing fatal asphyxiation
  • ✓Monitoring: Continuous arterial line blood pressure monitoring, continuous pulse oximetry, continuous ECG telemetry, large-bore dual peripheral IV access (14-16 gauge) or central venous catheter, and strict hourly blood loss volume quantification
  • ✓IV Hydration: Aggressive crystalloid volume resuscitation with 0.9% Normal Saline or Lactated Ringer's; immediate transfusion of Packed Red Blood Cells, Fresh Frozen Plasma, and Platelets (1:1:1 balanced massive transfusion protocol) to correct hemorrhagic shock and coagulopathy (target INR < 1.5, platelets > 50,000/uL)
  • ✓Pharmacotherapy (Generic Only): SYSTEMIC ANTIFIBRINOLYTIC THERAPY: Tranexamic Acid 1000 mg (1 g) IV bolus infused over 10 minutes, followed by 1000 mg IV every 8 hours (or continuous infusion of 10 mg/kg/hr); NEBULIZED ANTIFIBRINOLYTIC: Tranexamic Acid 500 mg nebulized in 5 mL 0.9% Normal Saline every 6-8 hours for active bleeding; ENDOBRONCHIAL VASOCONSTRICTION (During Bronchoscopy): Cold 0.9% Normal Saline aliquots (4°C, 50 mL) instilled into the bleeding bronchus PLUS Epinephrine 1:20,000 (1 mL of 1:1000 diluted in 19 mL saline; instill 2-5 mL aliquots, max 10 mL); COAGULOPATHY REVERSAL: If Warfarin-induced: Prothrombin Complex Concentrate 25-50 units/kg IV PLUS Vitamin K (Phytonadione) 10 mg IV slow push; If Heparin-induced: Protamine Sulfate 1 mg per 100 units of Heparin given in preceding 2 hours; BRONCHIAL ARTERY EMBOLIZATION (BAE - DEFINITIVE GOLD STANDARD): Urgent Bronchial Artery Embolization by Interventional Radiology to selectively catheterize and embolize culprit systemic bronchial arteries; AIRWAY CONTROL (If Asphyxiation Imminent): Endotracheal intubation with a large single-lumen tube (size 8.0-8.5 mm to allow therapeutic bronchoscope passage) or selective right/left mainstem bronchus intubation to isolate the unaffected lung; balloon catheter tamponade (Fogarty catheter) deployed endobronchially into bleeding lobar orifice

⚠️ علائم خطر حیات (Red Flags):

  • !Imminent asphyxiation and respiratory arrest secondary to complete occlusion of the tracheobronchial tree with clotted blood
  • !Inadvertent anterior spinal artery (artery of Adamkiewicz) embolization during bronchial artery angiographic embolization, resulting in spinal cord ischemia and irreversible paraplegia
  • !Re-bleeding catastrophe following initial stabilization requiring emergent thoracotomy and lung resection

پنومونی حاد ائوزینوفیلیک (AEP)

(Acute Eosinophilic Pneumonia (AEP))
ICD-10: J82.83مرجع: Murray & Nadel's Textbook of Respiratory Medicine - Ch. 66

📋 نکات شرح حال (History Pearls):

  • •Clinical onset & duration: Acute onset of febrile hypoxemic respiratory illness developing over <= 1 month (frequently < 7 days), progressing rapidly to acute respiratory distress syndrome
  • •Smoking and environmental triggers: Striking association with recent cigarette smoking initiation, resumption of smoking after a period of abstinence, change in smoking brand, exposure to hookah/waterpipes, e-cigarette/vaping use, or heavy exposure to organic dusts and fireworks smoke
  • •Constitutional symptoms: High fevers, chills, diaphoresis, non-productive cough, acute dyspnea, pleuritic chest pain, and severe myalgias

🩺 معاینه فیزیکی (Physical Exam):

  • •Respiratory status & auscultation: Marked tachypnea (RR > 30-35 breaths/min), intercostal retractions, cyanosis, and diffuse bilateral inspiratory crackles and rhonchi auscultated throughout both lung fields
  • •Vital signs: High fever (temperature >= 38.5-39.5°C), tachycardia, hypotension in severe cases; absence of cutaneous rash or systemic vasculitic signs
  • •Pleural signs: Decreased breath sounds and dullness to percussion at lung bases indicating bilateral pleural effusions (present in > 60% of AEP patients)

🧪 آزمایشگاه و تصویربرداری:

  • •Diagnostic Bronchoalveolar Lavage (BAL - PATHOGNOMONIC): Bronchoalveolar lavage fluid demonstrating marked eosinophilia > 25% of total nucleated cells (frequently > 40-50%); essential to establish diagnosis and rule out infectious pneumonia
  • •Peripheral Blood Eosinophil Discrepancy: Peripheral blood eosinophils are characteristically NORMAL or low at initial presentation (eosinophils are sequestered within the lung parenchyma); peripheral eosinophilia develops several days later during the recovery phase
  • •Imaging & Diagnostic Studies: Chest Radiography & HRCT demonstrate bilateral diffuse ground-glass opacities, smooth interlobular septal thickening (resembling hydrostatic pulmonary edema), patchy consolidations, and small bilateral pleural effusions; Pleural fluid analysis shows marked eosinophilia (pleural fluid eosinophils > 10-20%); Complete blood count shows marked leukocytosis with neutrophilia initially

💊 دستورات بستری و درمانی (Generic INN):

  • ✓Diet/Activity: Strict NPO during acute respiratory distress; bed rest in semi-Fowler position; strict avoidance of any further cigarette smoking, vaping, or toxin exposures
  • ✓Monitoring: Continuous pulse oximetry, continuous arterial line monitoring for arterial blood gas analysis every 4-6 hours, continuous cardiac telemetry, and serial chest radiographs tracking resolution
  • ✓IV Hydration: Conservative intravenous crystalloid hydration with 0.9% Normal Saline at 50-75 mL/hr; avoid fluid overload which worsens pulmonary capillary leak and gas exchange
  • ✓Pharmacotherapy (Generic Only): HIGH-DOSE SYSTEMIC CORTICOSTEROIDS (Prompt Dramatic Response): Methylprednisolone 60-125 mg IV every 6 hours (or 1-2 mg/kg/day) for the first 3-5 days until clinical improvement and extubation; switch to oral Prednisone 40-60 mg daily, tapering over 2-4 weeks (relapses are exceptionally rare once treated, unlike chronic eosinophilic pneumonia); EMPIRIC ANTIMICROBIAL THERAPY (Pending BAL infectious workup): Ceftriaxone 2 g IV every 24 hours PLUS Azithromycin 500 mg IV every 24 hours (discontinue once BAL confirms eosinophilia and excludes bacterial/atypical pneumonia); SUPPORTIVE RESPIRATORY THERAPY: High-Flow Nasal Cannula (HFNC) or mechanical ventilation utilizing low tidal volume ARDSNet protocol if severe ARDS develops; GASTROPROTECTION & VTE PROPHYLAXIS: Pantoprazole 40 mg IV daily PLUS Enoxaparin 40 mg subcutaneous once daily

⚠️ علائم خطر حیات (Red Flags):

  • !Rapid progression to fulminant ARDS with PaO2/FiO2 < 100 mmHg requiring emergent endotracheal intubation within 24-48 hours of symptom onset
  • !Failure to rapidly respond to systemic corticosteroids within 24-48 hours (virtually pathognomonic response in AEP; lack of response mandates immediate reassessment for fungal infection, PCP, or vasculitis)
  • !Development of pneumothorax or barotrauma during mechanical ventilation in patients with non-compliant, stiff lungs

حمله حاد پنومونیت ناشی از حساسیت مفرط (آلوئولیت آلرژیک خارجی)

(Acute Hypersensitivity Pneumonitis Flare (Extrinsic Allergic Alveolitis))
ICD-10: J67.9مرجع: Murray & Nadel's Textbook of Respiratory Medicine - Ch. 67

📋 نکات شرح حال (History Pearls):

  • •Exposure temporal profile: Acute onset of symptoms occurring 4 to 8 hours following heavy, intermittent exposure to a specific inhaled environmental organic antigen or low-molecular-weight chemical
  • •Antigen source identification: Avian proteins (bird fancier's lung: pigeons, parrots, parakeets, down feather duvets/pillows), thermophilic actinomycetes / moldy hay (farmer's lung), contaminated humidifiers/air conditioners (humidifier lung), hot tubs / spa pools (Mycobacterium avium complex in hot tub lung), or isocyanates (chemical worker's lung)
  • •Clinical symptom constellation: Abrupt flu-like illness: high fever, shaking chills, profuse diaphoresis, malaise, severe dyspnea, and non-productive cough, which characteristically improves or resolves within 24-48 hours of antigen avoidance, only to recur upon re-exposure

🩺 معاینه فیزیکی (Physical Exam):

  • •Vital signs & acute systemic reaction: Fever (temperature up to 39.0-40.0°C), tachycardia, tachypnea (RR > 28-32 breaths/min), and resting oxygen desaturation
  • •Pulmonary auscultation: Bibasilar end-inspiratory fine crackles auscultated across the mid-to-lower lung fields, often accompanied by high-pitched inspiratory wheezing or 'squeaks' (indicating bronchiolar involvement / bronchiolitis obliterans)
  • •Absence of systemic signs: Absence of wheezing characteristic of asthma; absence of digital clubbing (clubbing indicates chronic fibrotic HP, not acute flare); absence of rash or joint synovitis

🧪 آزمایشگاه و تصویربرداری:

  • •High-Resolution CT (HRCT Chest): Diffuse, bilateral, poorly defined centrilobular ground-glass nodules; mosaic attenuation pattern with areas of air trapping on expiratory imaging (reflecting bronchiolitis); 'three-density sign' or 'headcheese sign' (combination of ground-glass, normal lung, and air trapping/hypoattenuation)
  • •Bronchoalveolar Lavage (BAL Fluid Analysis): Marked lymphocytic alveolitis (lymphocyte differential typically > 30-50%, often exceeding 60%); low CD4+/CD8+ ratio (< 1.0, often < 0.5); plasma cells and occasional mast cells
  • •Serum Specific IgG Precipitins & Functional Testing: Detection of serum precipitating IgG antibodies against suspected antigens (e.g., avian antigens, Saccharopolyspora rectivirgula); Complete blood count showing marked leukocytosis with left shift (absence of significant eosinophilia); Pulmonary function tests demonstrating acute restrictive ventilatory defect with markedly reduced DLCO

💊 دستورات بستری و درمانی (Generic INN):

  • ✓Diet/Activity: Strict avoidance of the inciting antigen (ABSOLUTE CORNERSTONE OF THERAPY; permanent removal of pet birds, down bedding, or mold sources, or complete environmental remediation); bed rest in semi-Fowler position; supplemental oxygen during acute hypoxemic phase
  • ✓Monitoring: Continuous pulse oximetry, serial vital signs every 2-4 hours, serial pulmonary function testing (monitoring DLCO and FVC recovery), and repeat HRCT at 1-3 months post-exposure cessation
  • ✓IV Hydration: 0.9% Normal Saline at 50-75 mL/hr to maintain euvolemia during febrile illness; avoid overhydration
  • ✓Pharmacotherapy (Generic Only): ANTIGEN REMOVAL (Primary intervention): Complete cessation of antigen exposure leads to spontaneous resolution in many acute cases; SYSTEMIC CORTICOSTEROIDS (For severe acute symptoms, marked hypoxemia, or progressive deterioration): Methylprednisolone 60-125 mg IV every 8-12 hours for 1-3 days; transition to oral Prednisone 0.5-1 mg/kg/day (typically 40-60 mg daily) for 1-2 weeks, followed by a gradual taper over 4-8 weeks; INHALED BRONCHODILATORS (For symptomatic bronchospasm / squeaks): Albuterol 2.5 mg nebulized every 4-6 hours PRN; OXYGEN THERAPY: Titrate supplemental oxygen via nasal cannula or high-flow nasal cannula to maintain SpO2 >= 92%; GASTROPROTECTION: Pantoprazole 40 mg orally/IV daily during corticosteroid therapy

⚠️ علائم خطر حیات (Red Flags):

  • !Progression to acute respiratory failure with severe hypoxemia requiring high-flow nasal cannula or mechanical ventilation
  • !Failure to identify and eliminate the occult environmental antigen, resulting in recurrent subacute/acute flares that progress to irreversible, fatal fibrotic hypersensitivity pneumonitis
  • !Superimposed bacterial or opportunistic infection emerging during high-dose systemic corticosteroid therapy

پنومونیت حاد ناشی از اشعه (پرتودرمانی)

(Acute Radiation Pneumonitis)
ICD-10: J70.0مرجع: Murray & Nadel's Textbook of Respiratory Medicine - Ch. 73

📋 نکات شرح حال (History Pearls):

  • •Temporal relationship to radiotherapy: Development of symptoms classically occurs 4 to 12 weeks (peak 6-8 weeks) following the completion of thoracic radiation therapy (for lung cancer, breast cancer, esophageal cancer, thymoma, or lymphoma)
  • •Radiation dosimetric factors: Strongly correlated with the volume of normal lung irradiated; mean lung dose > 20 Gy, V20 (percentage of lung volume receiving >= 20 Gy) > 30-35%, concomitant chemotherapy (taxanes, gemcitabine, doxorubicin), and prior bleomycin exposure
  • •Symptom presentation: Insidious or abrupt onset of persistent, dry, hacking non-productive cough, progressive dyspnea on exertion and at rest, low-grade to high fever, pleuritic or dull aching chest discomfort, and severe fatigue

🩺 معاینه فیزیکی (Physical Exam):

  • •Thoracic auscultation: Localized or diffuse fine inspiratory crackles auscultated primarily within the irradiated lung zones, occasionally with a localized pleural friction rub
  • •Cutaneous radiation markers: Cutaneous radiation erythema, hyperpigmentation, induration, or telangiectasias strictly conforming to the radiation portal fields
  • •Signs of severe pulmonary parenchymal involvement: Tachypnea, central cyanosis, tachycardia, and resting hypoxemia (SpO2 < 90% on room air)

🧪 آزمایشگاه و تصویربرداری:

  • •High-Resolution CT Chest (GEOMETRIC CONFINEMENT): Demonstrates ground-glass opacities, consolidations with air bronchograms, and hazy interstitial thickening that classically CONFORMS SHARPLY TO THE SHAPE OF THE RADIATION PORTAL (crosses non-anatomical boundaries and interlobar fissures, with a straight edge demarcating the radiation beam margin); 'radiation recall' or out-of-field infiltrates may occasionally occur with concurrent immunotherapy (checkpoint inhibitors)
  • •Pulmonary Function Tests (PFTs): Marked reduction in diffusing capacity for carbon monoxide (DLCO is the most sensitive early physiologic parameter), accompanied by restrictive ventilatory defect (reduced TLC and FVC)
  • •Bronchoscopy & Infection Exclusion: Flexible bronchoscopy with bronchoalveolar lavage (BAL) is essential to exclude radiation-induced opportunistic infections (Pneumocystis jirovecii, fungal pneumonia, bacterial superinfection, CMV) or progressive tumor recurrence; BAL demonstrates lymphocytosis and occasional atypical reactive pneumocytes

💊 دستورات بستری و درمانی (Generic INN):

  • ✓Diet/Activity: High-protein oral nutrition; bed rest with elevated head of bed; strict smoking cessation; permanent avoidance of further thoracic radiotherapy during the acute inflammatory phase
  • ✓Monitoring: Continuous pulse oximetry, serial resting and exertional oxygen saturation testing, periodic pulmonary function tests (monitoring FVC and DLCO recovery), and repeat HRCT at 6 and 12 weeks
  • ✓IV Hydration: Maintenance crystalloid infusion with 0.9% Normal Saline at 50-75 mL/hr; maintain euvolemia; avoid volume overexpansion
  • ✓Pharmacotherapy (Generic Only): HIGH-DOSE SYSTEMIC CORTICOSTEROIDS (Mainstay of Treatment): Prednisone 60 mg orally daily (or 1 mg/kg/day; Methylprednisolone 60 mg IV every 12 hours if severe/hospitalized) for 2 to 4 weeks; CRUCIAL: Must implement an EXTREMELY SLOW, GRADUAL TAPER over 8 to 12 weeks (rapid steroid tapering frequently triggers a severe, catastrophic rebound pneumonitis flare); EMPIRIC ANTIMICROBIAL COVERAGE (Pending BAL results): Levofloxacin 750 mg orally/IV daily PLUS Trimethoprim-Sulfamethoxazole 160/800 mg orally twice daily (covers community-acquired pathogens and Pneumocystis jirovecii); COUGH SUPPRESSION: Codeine Phosphate 15-30 mg orally every 4-6 hours PRN or Dextromethorphan 30 mg orally every 6-8 hours for exhausting intractable non-productive cough; GASTROPROTECTION: Pantoprazole 40 mg orally/IV daily throughout high-dose corticosteroid treatment

⚠️ علائم خطر حیات (Red Flags):

  • !Rapid steroid withdrawal leading to fulminant rebound radiation pneumonitis with bilateral out-of-field organizing pneumonia and acute respiratory failure
  • !Severe steroid-induced opportunistic infections (especially Pneumocystis jirovecii pneumonia, invasive aspergillosis, or systemic candidiasis)
  • !Progression to irreversible radiation pulmonary fibrosis with dense volume loss, traction bronchiectasis, severe cor pulmonale, and chronic oxygen dependency

افیوژن پلورال بدخیم نیازمند تعبیه کاتتر ماندگار (IPC/Pleurodesis)

(Malignant Pleural Effusion & Indwelling Pleural Catheter (IPC))
ICD-10: J91.0مرجع: Murray & Nadel's Textbook of Respiratory Medicine - Ch. 79

📋 نکات شرح حال (History Pearls):

  • •Primary oncologic presentation: Exudative pleural effusion in a patient with known or newly diagnosed disseminated malignancy (most commonly lung adenocarcinoma, breast carcinoma, malignant pleural mesothelioma, ovarian cancer, or lymphoma)
  • •Symptom progression & lung entrapment: Progressive, severe exertional and resting dyspnea, dull non-pleuritic ipsilateral chest ache/heaviness, dry cough, profound fatigue, cachexia, and anorexia; history of prior therapeutic thoracentesis with rapid symptomatic recurrence within days to weeks
  • •Quality of life and functional goals: Assessment of performance status (ECOG / Karnofsky score), expected survival, and presence of 'trapped lung' (non-expandable lung secondary to visceral pleural tumor encasement or proximal endobronchial obstruction preventing lung re-expansion after fluid drainage)

🩺 معاینه فیزیکی (Physical Exam):

  • •Percussion & auscultation findings: Massive stony dullness to percussion extending over the lower and mid-hemithorax, absent tactile fremitus, and severely diminished or absent breath sounds on the affected side
  • •Tracheal & mediastinal shifts: Massive effusion may displace the trachea and mediastinum contralaterally; however, if the ipsilateral hemithorax has central airway obstruction or trapped lung, the mediastinum may remain midline or shift IPSILATERALLY despite a large effusion
  • •Oncologic physical examination: Supraclavicular or axillary malignant lymphadenopathy, mastectomy scar or primary breast mass, cachexia, temporal wasting, and digital clubbing

🧪 آزمایشگاه و تصویربرداری:

  • •Diagnostic Thoracentesis & Pleural Fluid Cytology: Exudative effusion by Light's criteria (Pleural/Serum protein ratio > 0.5, Pleural/Serum LDH ratio > 0.6, or Pleural LDH > 2/3 upper limit of normal); grossly bloody or serosanguinous fluid; pleural fluid cytology confirms malignant cells (sensitivity ~60% on first tap, rises to ~75-80% on second tap); molecular testing (EGFR, ALK, ROS1, PD-L1, KRAS) performed directly on pleural fluid cell blocks
  • •Contrast-Enhanced Chest CT & Pleural Ultrasound: Nodular, circumferential pleural thickening (> 1 cm), mediastinal pleural involvement, diaphragmatic thickening, and underlying pulmonary atelectasis versus central obstructing mass; thoracic ultrasound identifies septations and guides safe drainage
  • •Post-Drainage Chest Radiography: Crucial assessment of lung re-expansion post-thoracentesis; failure of the visceral pleura to appose the parietal chest wall confirms 'trapped lung / lung entrapment' (absolute indication for Indwelling Pleural Catheter and contraindication to chemical pleurodesis)

💊 دستورات بستری و درمانی (Generic INN):

  • ✓Diet/Activity: High-protein, high-calorie palliative oral diet; semi-Fowler position; encourage gentle ambulation to maintain functional independence
  • ✓Monitoring: Continuous pulse oximetry during procedures, monitoring drainage volume (limit single drainage to <= 1000-1500 mL to prevent re-expansion pulmonary edema), tracking pain score, and daily inspection of catheter insertion site for cellulitis or tumor seeding
  • ✓IV Hydration: Maintenance 0.9% Normal Saline at 50-75 mL/hr if needed; avoid excessive fluid administration which can increase pleural fluid accumulation
  • ✓Pharmacotherapy (Generic Only): DEFINITIVE PLEURAL PALLIATIVE INTERVENTIONS: INDWELLING PLEURAL CATHETER (IPC - First-Line for Trapped Lung or Outpatient Care): Insertion of a tunneled, cuffed Indwelling Pleural Catheter under local anesthesia, with scheduled home drainage (e.g., 500-1000 mL every 2-3 days using vacuum bottles); CHEMICAL PLEURODESIS (Only if fully expandable lung confirmed on drainage): Instillation of sterile Talc slurry 4-5 g suspended in 50 mL 0.9% Normal Saline via chest tube (or Talc poudrage during thoracoscopy); OR Doxycycline 500 mg in 50 mL 0.9% Normal Saline; LOCAL ANESTHESIA & ANALGESIA: Lidocaine 1% or 2% (up to 3 mg/kg) for local infiltration during catheter placement; Paracetamol 1000 mg orally/IV every 6 hours PLUS Morphine 2.5-5 mg orally/IV every 4 hours PRN for pleuritic pain; PROPHYLACTIC ANTIMICROBIALS (Only if IPC site infection / pleural infection occurs): Cefazolin 1-2 g IV every 8 hours OR Vancomycin 15-20 mg/kg IV every 12 hours

⚠️ علائم خطر حیات (Red Flags):

  • !Re-expansion pulmonary edema occurring during or immediately following rapid evacuation of > 1.5 liters of pleural fluid; presents with severe coughing, pink frothy sputum, and acute respiratory failure
  • !Indwelling catheter-related pleural space infection or empyema presenting with high fevers, purulent drainage, and septic shock
  • !Malignant tumor seeding along the catheter track or chest wall incision sites

آسپیراسیون حاد جسم خارجی به تراکئوبرونشیال

(Acute Tracheobronchial Foreign Body Aspiration)
ICD-10: T17.408Aمرجع: Murray & Nadel's Textbook of Respiratory Medicine - Ch. 24

📋 نکات شرح حال (History Pearls):

  • •Aspiration episode history: Sudden, abrupt onset of violent choking, paroxysmal coughing spasms, gagging, stridor, or cyanosis while eating or holding objects in mouth ('penetration syndrome'); NOTE: In elderly, intoxicated, or neurological patients, the choking event may be unwitnessed, leading to delayed presentation
  • •Delayed / occult presentation: Unilateral non-resolving pneumonia, recurrent localized atelectasis, chronic cough, unilateral refractory wheezing, or lung abscess unresponsive to repeated courses of antibiotics
  • •Nature of aspirated material: Organic foreign bodies (peanuts, nuts, seeds, bones, vegetable matter - induce intense local chemical bronchitis, swelling, granulation tissue, and distal obstruction) versus inorganic foreign bodies (dental fragments, crowns, pins, plastic caps)

🩺 معاینه فیزیکی (Physical Exam):

  • •Tracheal / Laryngeal obstruction signs (Complete/Subtotal): Inability to speak, aphonia, inspiratory stridor, frantic clutching of the throat (universal choking sign), severe cyanosis, and rapid loss of consciousness
  • •Bronchial obstruction physical signs: Classic triad (present in < 40-50%): unilateral wheezing, localized decreased breath sounds, and paroxysmal cough; unilateral hyperresonance (air-trapping / ball-valve effect) or unilateral dullness (total obstruction with atelectasis)
  • •Adventitious sounds: Monophonic fixed inspiratory/expiratory wheeze auscultated over a localized bronchial territory; audible 'slap' or palpable 'thud' over the trachea as a mobile foreign body impacts the subglottis

🧪 آزمایشگاه و تصویربرداری:

  • •Rigid & Flexible Bronchoscopy (GOLD STANDARD DIAGNOSTIC & THERAPEUTIC): Rigid bronchoscopy under general anesthesia is the procedure of choice for foreign body extraction (provides secure airway, excellent optical visualization, and allows passage of heavy extraction forceps, optical grasping forceps, or cryotherapy probes); flexible bronchoscopy is excellent for peripheral segmental foreign bodies
  • •Inspiratory and Expiratory Chest Radiography: Only 10-15% of foreign bodies are radio-opaque (teeth, coins, pins, bone fragments); indirect radiological signs: unilateral hyperinflation with air trapping (especially visible on forced expiratory or lateral decubitus films), mediastinal shift away from the affected side during expiration, obstructive atelectasis/lobar collapse, or post-obstructive consolidation
  • •Multidetector Virtual Bronchoscopy / Thoracic CT: CT scan with virtual 3D tracheobronchial reconstruction has > 95-100% sensitivity for detecting radiolucent organic foreign bodies, impaction depth, surrounding granulation tissue, and bronchial wall perforation

💊 دستورات بستری و درمانی (Generic INN):

  • ✓Diet/Activity: Strict NPO immediately upon suspicion; bed rest; keep patient calm, avoiding agitation or vigorous back blows in a stable conscious patient which can dislodge a bronchial foreign body into the subglottis and cause complete tracheal asphyxiation
  • ✓Monitoring: Continuous pulse oximetry, continuous ECG telemetry, automated blood pressure monitoring, prepare difficult airway cart and rigid bronchoscopy equipment in operating room
  • ✓IV Hydration: Maintenance crystalloid infusion with 0.9% Normal Saline or Lactated Ringer's at 50-75 mL/hr; maintain secure IV access
  • ✓Pharmacotherapy (Generic Only): ANESTHESIA & RIGID BRONCHOSCOPIC REMOVAL: Emergent or urgent intervention in operating room under general anesthesia (Propofol 1-2 mg/kg IV, Remifentanil 0.1-0.5 mcg/kg/min IV, and Rocuronium 0.6-1.0 mg/kg IV once airway control is established); extraction using specialized grasping forceps, Dormia baskets, or cryoprobe; LOCAL TOPICAL VASOCONSTRICTION & EDEMA CONTROL: Topical Epinephrine 1:10,000 (1-2 mL applied via bronchoscope directly to bleeding/edematous mucosa surrounding the object); POST-EXTRACTION CORTICOSTEROIDS (To reduce subglottic and bronchial mucosal edema): Dexamethasone 4-8 mg IV every 8 hours (or Methylprednisolone 40 mg IV every 8 hours) for 24-48 hours; POST-OBSTRUCTIVE ANTIMICROBIAL THERAPY (For secondary bacterial superinfection or lung abscess): Ampicillin-Sulbactam 3 g IV every 6 hours OR Amoxicillin-Clavulanate 875/125 mg orally every 8 hours (or Ceftriaxone 2 g IV every 24 hours PLUS Metronidazole 500 mg IV every 8 hours) for 5-7 days; BRONCHODILATOR THERAPY: Albuterol 2.5 mg nebulized every 4 hours PRN for post-procedure reactive bronchospasm

⚠️ علائم خطر حیات (Red Flags):

  • !Complete tracheal or laryngeal obstruction resulting in immediate asphyxiation and cardiac arrest (mandates emergent Heimlich maneuver, direct laryngoscopy, or emergent surgical cricothyroidotomy)
  • !Dislodgement of a foreign body from a mainstem bronchus into the subglottis during extraction attempts, converting a partial bronchial obstruction into fatal complete airway obstruction
  • !Iatrogenic or mechanical bronchial wall laceration/rupture with pneumomediastinum, massive subcutaneous emphysema, or tension pneumothorax